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ABSTRACT 
Activation of pyruvate dehydrogenase (PDH), which converts pyruvate into acetyl-CoA, 
is accomplished by a pair of specific phosphatases (PDP 1 & 2). A cross-sectional study 
investigating the effect of aerobic capacity on PDP activity and expression found that: 1) 
PDP activity and PDP! protein expression were positively correlated with most aerobic 
capacity measures in males (n=lS), but not females (n=12); 2) only males showed a 
positive correlation between PDP activity and PDPl protein expression (r=0.47; p=O.05), 
indicating that the increase in PDP activity in males is largely explained by increased 
PDPl protein expression, but that females rely on another level for PDP activity 
regulation; and 3) PDP} and Ela protein expression increase in unison when expressed 
relative to the E2 core. These data suggest that with increased aerobic capacity there is 
an increased capacity for carbohydrate oxidation through PDH, via El a, and an increased 
ability to activate PDH, via PDP, when exercising maximally. 
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CHAPTER 1: 
INTRODUCTION 
The human body has many processes in place to react to a variety of stressors in 
order to maintain a state of homeostasis. This homeostasis is required for blood glucose 
levels, as they must be kept at a stable level in order for the body to function properly. 
This homeostasis is accomplished by glucose uptake by the cells of the body whenever 
blood glucose levels rise or the release of glucose from the cells whenever blood glucose 
levels become low. Once inside the cell, glucose can be: stored as glycogen; broken 
down through glycolysis and regenerated through gluconeogenesis; or oxidized. The key 
enzyme regulating carbohydrate oxidation is pyruvate dehydrogenase (PDH), with this 
enzyme being of particular importance in skeletal muscle because the large mass of this 
tissue in the body represents a major site for glucose disposal and whole body glucose 
homeostasis. In addition, small changes in energy demand through, for example, exercise 
will cause large overall demand for glucose oxidation and changes in active PDH (PDHa) 
activity (Fuller & Randle, 1984, Peters et at, 2001 b). As PDH itself is regulated by a 
pair of specific phosphatases (PDP 1 & 2; activation) and four kinases (PDKl-4; 
inactivation), the activity of these regulatory enzymes is of great importance in skeletal 
muscle in determining overall glucose oxidation, especially during exercise and the 
adaptations that occur as a result of aerobic exercise training. This thesis describes a 
cross-sectional study in which the activity of PDP is measured in human skeletal muscle 
in subjects of varying aerobic capacities. Additionally, the protein expression of the 
calcium-sensitive, and predominant skeletal muscle PDP isoform, PDPl, will also be 
measured to determine any correlations with aerobic capacity and total PDP activity. 
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LITERATURE REVIEW 
PDH Function 
PDH acts as the link between glycolysis and oxidative phosphorylation through 
the irreversible conversion of pyruvate to acetyl-CoA. This step is the first irreversible 
reaction in carbohydrate oxidative metabolism with the stoichiometry of the reaction 
being: pyruvate + CoA-SH + NAD+ ----> acetyl-CoA + CO2 + NADH + H+ (as reviewed 
by Wieland, 1983). This reaction is made irreversible by the cleaving off of a carbon 
which is released as carbon dioxide. As PDH exists in both an active and inactive form 
(which will be discussed later), it acts as a gateway for carbohydrate-derived pyruvate to 
acetyl-CoA, and can indirectly regulate fat oxidation by determining the proportion of 
acetyl-CoA from the two major energy sources. In its inactive form, the oxidative 
disposal of carbohydrate is restricted, which can increase fat oxidation to generate acetyl-
CoA units for the TCA cycle, allowing the continuation of oxidative metabolism to meet 
the energy demand. 
PDH Structure 
The PDH complex is located in the matrix ofthe mitochondria and has been 
found to be in close proximity to the inner membrane (Matlib & O'Brien, 1975, Stanley 
& Perham, 1980). Little research has been conducted to date determine ifthere is a more 
structured distribution of this complex in the mitochondria. However, a study by 
Margineantu et al. (2002) investigated the distribution ofPDH in the mitochondria, 
through staining, with the discovery that there were regions within the cristae containing 
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higher concentrations ofPDH (Ela and E2) interspersed with regions that appeared to be 
void ofPDH. Moreover, these dispersions remained stable for time periods longer than 
2hrs, leading the authors to postulate that PDH may be anchored to the inner 
mitochondrial membrane. 
PDH is composed of three different subunits, with each subunit playing a specific 
role in the conversion of pyruvate to acetyl-CoA. The reaction is initiated at the El 
(pyruvate dehydrogenase) subunit with the cleaving ofa carbon off the pyruvate 
molecule to form CO2 and an acetyl intermediate. The El subunit is a heterotetramer and 
is composed of both an a and ~ subunit (Reed, 1974), with the active site located at the 
interface of the a and ~ subunits (Ciszak et aI., 2003). This step also requires the cofactor 
thiamine pyrophosphate (TPP) which is bound in the cleft between the a and ~ subunits 
(Gutowski & Lienhard, 1976, Robinson & Chun, 1993). The El reaction is responsible 
for the irreversible nature of the PDH reaction because ofthe CO2 that is lost at this stage, 
however, the remaining reactions in the PDH reaction have the capacity to go in either 
direction (Ravindran et aI., 1996). This step is also recognized as being the rate-limiting 
step for the PDH reaction (Cate et aI., 1980). The Ela subunit is well recognized as 
being the site ofPDH activity regulation because ofthe presence of three serine residues, 
which will be discussed in the next section. Following the Ela reaction, the acetyl 
intermediate is passed to the E2 ( dihydrolipoyl transacetylase) subunit where it is 
oxidized, combined with CoA, and released as acetyl-CoA. This reaction leaves the E2 
subunit in a reduced form, and it must therefore be re-oxidized before accepting another 
acetyl intermediate. This is accomplished via the E3 ( dihydrolipoyl dehydrogenase) 
subunit, which oxidizes the E2 subunit (becoming reduced itself) and then passing these 
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electrons on to NAD+ to fonn NADH through an FAD-linked reaction (see Figure 1.1; as 
reviewed by Behal et aI., 1993). Lastly, the complex contains an E3 binding protein 
(E3BP) which is responsible for binding the E3 subunit to the core (see Figure 1.2; 
Gopalakrishnan et aI., 1989). Additionally, each PDH complex is not composed of a 
single copy of each subunit, but is in fact composed of multiple copies of each subunit. 
In a study on purified PDH complex from bovine kidney, it was found that the complex is 
composed of30 El subunits arranged in a heterotetramer, 6 E3 subunits existing as a 
homodimer, and 60 E2 subunits which fonn the core ofthe complex (Zhou et aI., 2001). 
However, a more recent study using prepared homogenous human components found that 
the core of the complex may be composed of a different stoichiometry, with 48 E2 
subunits and 12 E3BP subunits fonning a pentagonal dodecahedral core for the complex 
(Hiromasa et at, 2004). More recent analysis by Brautigam et al. (2009) on purified 
recombinant human PDH subunits shows a different stoichiometry, with a core of 40 E2 
subunits and 20 E3BP subunits. There is also an E2 'swinging ann' extending from the 
core that has two lipoyl binding domains for shuttling intennediates between active sites 
as well as binding and moving the regulatory enzymes between the El subunits and an EI 
binding domain allowing El subunit binding to the E2 core (Liu et aI., 1995, Reed & 
Hackert, 1990). Also extending from the core are linker regions of E3BP which connect 
to the E3 subunit binding domain as well as a third lipoyl binding domain (Rahmatullah 
et al 1989a, Rahmatullah et al 1989b). Smolle et al. (2006) found that there may be 
further interactions occurring in the PDH complex based on the stoichiometries of the 
complex subunits. Their findings suggested that there are "'cross-bridges" fonned 
between two E3BPs by an E3 subunit (as they have a 2:1 stoichiometry), with the strong 
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possibility that these cross-bridges also occur between two E2 swinging arms by an E 1 
subunit (also with a 2:1 stoichiometry; Figure 1.3). This model also fits into the theory 
that the E2 swinging arm shuttles PDK around the complex as the regular spacing of the 
lipoyl domains ofE2 by the cross-bridges ofEl would allow for easier movement of 
PDK and convenient access to the El subunits. However, the findings of Brautigam et al. 
(2009) contradict the possibility of cross-bridges by showing that E3BP and E3 have a 
1: 1 stoichiometry (as does E2 and E 1), which is in stark contrast to the previously 
reported ratios of 2: 1. The total size of the native complex is approximately 8500 kDa. 
Aside from the native complex, there are also regulatory proteins that are also associated 
with the complex (as reviewed by Behal et aI., 1993), which will also be discussed in the 
following section. 
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Figure 1.1. Reactions of the three PDH subunits in converting pyruvate to acetyl-CoA. 
The E 1 subunit converts pyruvate to an acetyl intennediate, which is passed to E2 where 
CoA is added to the acetyl intennediate and it is released as acetyl-CoA. The E3 subunit 
then re-oxidizes E2, producing NADH + H+ from NAD+ in the process. Pyruvate 
dehydrogenase (EI); dihydrolipoyl transacetylase (E2); dihydrolipoyl dehydrogenase 
(E3). From Behal, et al. (1993). 
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Figure 1.2. Structure of the PDH complex. The inner E2 core with the extending 'super 
arm' which contains two lipoyl binding domains and the E 1 binding domain, where the 
E 1 subunit binds. Also attached to the E2 core is the E3 binding domain, where the E3 
subunit binds via the E3 binding protein (E3BP), and a third lipoyl binding domain. 
PDP, PDH phosphatase; PDK, PDH kinase; PRP, phosphatase regulatory protein; E1, 
pyruvate dehydrogenase; E2, dihydrolipoyl transacetylase; E3, dihydrolipoyl 
dehydrogenase. From Harris et al. (2002) 
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Figure 1.3. Model for cross-bridge fonnation in the PDH complex. The E3 homodimer 
binds to the subunit binding domains oftwo E3BPs to fonn a cross-bridge, with a similar 
cross-bridge being fonned between two E2 swinging anns at the E 1 binding domains by 
El. EI, pyruvate dehydrogenase; E2, dihydrolipoyl transacetylase; E3, dihydrolipoamide 
dehydrogenase; E2SBD, E2 subunit binding domain; XSBD, X subunit binding domain; 
PDK, PDH kinase; PDP, PDH phosphatase; PRP, phosphatase regulatory protein. From 
Smolle et al. (2006). 
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Acute Regulation of PDH 
Covalent Regulation 
PDH requires tight regulation in order to restrict the utilization of carbohydrates, 
as this fuel source is critical in certain situations and to certain tissues and has limited 
storage in the body (as reviewed by Harris et aI., 2002). This regulation is accomplished 
by PDH existing in both an active (PDHa) and inactive form (with the combination of 
these two forms being total PDH (PDHt)) and this activity being determined covalently 
by the binding of phosphate to serine residues located on the E 1 a subunit of the complex. 
The enzyme is rendered inactive by phosphorylation and is reactivated by 
dephosphorylation (see figure 1.4) (Linn et aI., 1969). There are three serine residues 
(Ser264, site 1; Ser271 , site 2; and Ser203 , site 3) located on each El a subunit (Sale & 
Randle, 1981, Teague et aI., 1979, Yearnan et aI., 1978). However, only one of the two 
E la subunits needs to be phosphorylated in order to inactivate the complex (Sugden & 
Randle, 1978). In addition to this, only one of these serine residues needs to be 
phosphorylated in order for the complex to be inactivated (Korotchkina & Patel, 1995). 
The binding of additional phosphates is considered to only make the complex more 
difficult to reactivate because of the additional time required to remove the extra 
. phosphates (Holness et aI., 1988, Holness & Sugden, 1989, Sugden & Holness, 1989). 
The different phosphorylation sites appear to inactivate PDH by different mechanisms. 
Site 1 (Ser264) is located at the substrate channel leading to the active site ofEla (Ciszak 
et aI., 2003, Seifert et aI., 2007) and appears to cause a steric, and to a lesser extent 
electrostatic, barrier to substrate binding at the active site, as well as preventing E2 lipoyl 
domain binding, when phosphorylated (Seifert et aI., 2007). The mechanism of 
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inactivation by site 2 and 3 phosphorylation is not known, however, it is postulated that 
phosphorylation of site 3 (Ser203) affects binding of thiamine pyrophosphate (TPP; a 
required cofactor for the E 1 a reaction). However, the complex is only rendered 
completely inactive when site 1 is phosphorylated, but is still capable of moderate 
catalytic activity when only sites 2 or 3 are phosphorylated (Korotchkina & Patel, 2001 a). 
Phosphorylation is accomplished by PDH kinases (PDK; Yeaman et aI., 1978) and 
dephosphorylation by PDH phosphatases (PDP; Teague et aI., 1979). Therefore, the 
activity ofPDHa is determined by the relative activities of the kinases and phosphatases 
(as reviewed by Harris et aI., 2002 and Sugden & Holness, 1994). 
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Figure 1.4. Covalent regulation ofPDH, with PDK adding phosphate to render the 
complex inactive, while PDP dephosphorylates PDH to reactivate the complex. There 
are three sites of phosphorylation on the complex. The activities ofPDK and PDP are 
determined by allosteric regulation. PDH, pyruvate dehydrogenase; PDK, PDH kinase; 
PDP, PDH phosphatase. 
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PDKs 
There are four PDK isofonns (PDKI-4), which display different activity levels, 
tissue expression, and allosteric regulation (Bowker-Kinley et aI., 1998, Gudi et aI., 
1995). PDK is largely activated by the products of the PDH reaction (acetyl-CoA and 
NADH) and increased energy charge (ATP) and is inhibited by the substrates (pyruvate, 
CoA, and NAD+) (Kolobova et aI., 2001). The products ofthe PDH reaction also 
enhance PDK activity by creating a build up of the acetylated fonn ofthe E2 component 
which enhances PDK binding to the lipoyl moiety, thereby increasing PDK activity 
because of its bound state (Ravindran et aI., 1996). However, as mentioned above, each 
PDK isofonn has a differing sensitivity to these regulators. Some important differences 
in regulation and specific activities are summarized in Figure 1.5. Additionally, each of 
the PDK isofonns has a different affinity towards the three phosphorylation sites on 
PDH. Three of the PDK isofonns and their site specificities are shown in Figure 1.6. Of 
particular note in these specificities is that PDKI is the only isofonn capable of 
phosphorylating site 3. Taken together, these results yield a phosphorylation rate in 
which site 1 is 4.6-fold more rapidly phosphorylated than site 2, and 16-fold more rapidly 
phosphorylated than site 3 (Korotchkina & Patel, 1995). These isofonns are also 
expressed at different concentrations in different tissues. Analysis of mRNA in rats 
showed that PDKI is found predominantly in the heart (Popov et ai., 1994, Bowker-
Kinley et aI., 1998) with smaller concentrations found in skeletal muscle, with the highest 
concentrations in the more oxidative fibre types (Peters et aI., 200Ia). PDK2 is expressed 
in high concentrations in all tissues, while PDK3 is also found in most tissues, but in 
much lower concentrations. PDK4 is mainly expressed in heart and skeletal muscle, with 
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the highest concentrations again being in the more oxidative fibre types (Peters et aI., 
2001a), but is also expressed in low amounts in the brain, liver, and pancreas (Bowker-
Kinleyet aI., 1998). Additionally, PDK exists in both a bound and unbound state in 
terms of its association to the E2 core ofthe complex, with the regulatory enzyme being 
more active in the bound state (Ono et aI., 1993). This is important, as a shift in the 
binding ofthe isoforms could affect the specific kinase activity without a change in the 
amount of kinase present (Korotchkina & Patel, 2001 b). 
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Figure 1.5. Rat PDK isoform activities and sensitivities to various effectors relative to the 
most abundant PDK isoform, PDK2. Adapted from Bowker-Kinley et al. (1998). 
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Figure 1.6. The specificity of the major skeletal muscle PDK isoforms toward the three 
regulatory sites on the PDH complex. Also depicted is the sensitivity ofthe PDK 
isoforms to the various allosteric regulators. PDC, PDH complex. From Sugden & 
Holness (2003). 
PDPs 
There are two known isoforms of PDP in the body (PDPl-2), with each of these 
also displaying different activity levels, tissue expression, and allosteric regulation 
(Huang et aI., 1998, Huang et aI., 2003, Kolobova et aI., 2001). Both isoforms require 
magnesium for activation (Huang et aI., 1998, Lawson et aI., 1993, Severson et aI., 1974), 
though PDP2 has approximately a 10-fold lower sensitivity towards Mg2+ than PDP! 
(Huang et aI., 1998). Although relatively little is known about the catalytic mechanism 
that PDP follows for dephosphorylation, it is believed that it follows a similar mechanism 
to that of other protein phosphatase 2C (PP2C) enzymes, which PDP is classified as 
(Vassylyev & Symersky, 2007). Metal-bound (Mn2+) water molecules coordinate the 
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phosphate group to the enzyme through hydrogen bonds with the oxygens of the 
phosphate group. It is then believed that a bimolecular nucleophilic substitution occurs 
with the metal-bound water molecules acting as nucleophiles causing the phosphate 
group to be expelled (Das et aI., 1996). In the case of PDP, however, the two Mn2+ ions 
are replaced with two Mg2+ ions. 
Activation of PDP is accomplished allosterically by calcium and also by insulin 
stimulation through a mechanism that is not yet fully understood. PDP} responds solely 
to calcium (Lawson et aI., 1993) while PDP2 is insensitive towards Ca2+ (Huang et aI., 
1998). Insulin has been shown to activate the PDH complex in skeletal muscle (Nakai, et 
aI., 1999, Denyer et aI., 1989) and epididymal adipose tissue (Jungas, 1971, Weiss et aI., 
1971) of rats, with this activation believed to be mediated through PDP (Thomas & 
Denton, 1986). Much research has gone into investigating the structure of PDP 1 to 
reveal that it is a heterodimer with a 52.6 kDa catalytic subunit (PDP 1 c) as well as a 96 
kDa regulatory subunit (PDPlr) (Teague et aI., 1982, Pratt et aI., 1982, Yan et aI., 1996). 
It is the PDPlc component that is stimulated by Ca2+ and requires Mg2+ for activity. Ca2+ 
stimulates activity by causing binding of PDP 1 c to the interior lipoyl-bearing (L2) 
domain of the E2 subunit, however, both ofthese components (PDPlc and L2) are 
required as Ca2+ is unable to bind to either component alone (Teague et aI., 1982, Yang et 
aI., 1998, Turkan et aI., 2004). Without Ca2+ stimulation, PDP} is very loosely bound to 
the PDH complex in comparison to the PDK isoforrns (Teague et aI., 1982). Structural 
analysis ofPDPlc revealed that this is likely due to a more open cavity present on this 
isoforrn, compared to the PDK isoforrns, which suggests that it must be closed to achieve 
tight binding to the E2lipoyl domain (Vassylyev & Symersky, 2007). A similar open 
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cavity was also found on the PDP2 isoform, which is insensitive to Ca2+ and has been 
found to not bind to the E2lipoyl domain (Huang et aI., 1998, Karpova et aI., 2004), 
leading to the theory that Ca2+ causes a conformational change in this cavity to allow 
tight binding to the PDH complex (Vassylyev & Symersky, 2007). Once bound to the E2 
subunit of the complex, PDPlc activity is greatly increased. However, the minimum 
subdomains ofE2 required for this increase in activity are L2 and the El binding domain, 
with the greatest increase in activity coming when the transacetylase (E2) domain is 
present with the L2 and E 1 binding domain, where activity is indistinguishable from that 
of the complete E2 complex or the fully assembled PDH complex (Karpova et aI, 2003). 
These findings lend support to the idea that the co-localization ofPDPlc and El through 
E2 binding account for the increase in PDP activity. The greater PDP activity seen when 
the transacetylase (E2) domain is also present could be interpreted to support the 
hypothesis that this component facilitates delivery ofPDPlc to the different EI subunits, 
thereby enhancing its function (Chen et aI., 1996, Karpova et aI., 2003, Pettit et aI., 
1972). 
The other PDP subunit, PDPlr, has an inhibitory effect on PDP activity by 
decreasing the sensitivity ofPDPlc for Mg2+ by modifying or blocking the PDPlc 
catalytic site (Yan et aI., 1996). It has also been found that PDPlr decreases the 
sensitivity ofPDPlc to Ca2+, leading to the belief that PDPlr plays a mediator role 
between the Ca2+ and Mg2+ binding sites as an increase in the level of one of these metal 
ions creates an increase in the sensitivity for the other metal (Turkan et aI., 2004). 
Vassylyev & Symersky (2007) suggest the presence of a low-affinity binding site for 
Mg2+ on PDPlr that is unoccupied at low concentrations ofMg2+, but binds Mg2+ 
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whenever higher concentrations of this ion are present. If this Mg2+ binding site is 
unoccupied, a proposed acidic side-chain ofPDPlr binds to the Mg2+ ion of the active 
site for PDP 1 c instead, thereby blocking access to the active site. However, if this Mg2+ 
binding site ofPDPlr becomes occupied, the acidic side chain would then switch to this 
internal Mg2+ ion instead, thereby opening up the active site of PDP 1 c. 
PDP is also further regulated through phosphorylation itself. Caruso et al. (2001) 
investigated the role of several isoforms in the protein kinase C (PKC) family on the 
activity of PDP in L6 skeletal muscle cells and immortalized hepatocytes. It was found 
that upon insulin stimulation all PKC isoforms (PKCa, -~, -8, -£, -s) translocated to the 
plasma membrane, with PKC8 also redistributing to the mitochondrial membrane, where 
. it co-localized with the PDP isoforms. Inhibition ofPKC8 was found to nearly eliminate 
the increase in PDH activity normally seen with insulin stimulation, with inhibition of 
PKCa and -s having no effect on PDH activity, indicating that PKC8 is the specific 
isoform responsible for the phosphorylation of PDP in muscle and liver cells (Caruso et 
aI., 2001). An earlier study investigating the activation ofPDH through insulin found 
that PKC activation is required for this process, in that when they inhibited PKC, insulin 
was unable to activate PDH (Benelli et aI., 1994). They also suggest that there may be a 
specific pathway for insulin signal transduction with several intermediary steps based on 
their finding that there was a lag in PDH activation by insulin, but PDH activation 
occurred much faster whenever 4~-phorbol 12~-myristate I 3 a-acetate (a PKC activator) 
was used directly to activate PKC (BeneIli et aI., 1994). However, another study found 
that increased PKC8 activity prevents recovery ofPDH activity during reperfusion, 
following ischemia, in heart mitochondria, with this prevention in activity inhibited when 
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PKCb translocation to the mitochondria is prevented (Churchill et aI., 2005). These 
contradictory findings for PKC, however, are suspected to be tissue specific (Dekker & 
Parker, 1994, Caruso et aI., 2001), as Caruso et al. (2001) investigated L6 skeletal muscle 
cells and immortalized hepatocytes, and Benelli et al. (1994) used hepatoma cells, while 
Churchill et al. (2005) used cardiac mitochondria. These tissue differences are also 
evident by the different half-lives for PKC activity, as PKC is rapidly degraded in 
hepatoma cells by 12-0-tetradecanoylphorbol-13-acetate, but degradation is delayed in 
3T3 fibroblasts (Lindner et aI., 1991), allowing for PDH to be activated longer in these 
tissues. However, it is not yet known if phosphorylation of PDP (or PDK) plays a 
physiological role in intact skeletal muscle. 
Inhibition of PDP is accomplished by NADH, acetyl-CoA, and ATP (as reviewed 
by Denton et aI., 1975 and Wieland, 1983). PDP also displays tissue specific properties 
which are essentially based on the activators of the two isoforms. PDP 1 (calcium-
sensitive) is expressed in heart, brain, skeletal muscle, and testis, while PDP2 (insensitive 
to calcium) is expressed to a greater degree in the more insulin-sensitive tissues such as 
liver and kidneys, as well as the heart and brain (Huang et aI., 2003), with some 
expression in skeletal muscle (Bajotto et aI., 2004, Huang et aI., 1998, LeBlanc et aI., 
2007). Although both PDP isoforms are present in skeletal muscle, there is a much 
greater concentration of PDP 1 than PDP2 in this tissue (Huang et aI., 2003, LeBlanc et 
aI.,2007). LeBlanc et al. (2007) have recently discovered that the expression of PDP 
within muscle is also fibre-type specific, with PDP 1 expression and PDP activity being 
significantly greater in red gastrocnemius and PDP2 detectable exclusively in red 
gastrocnemius (LeBlanc et aI., 2007). Dephosphorylation ofthe Ela subunit by PDP is 
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thought to occur randomly, demonstrating no site specificity (Korotchkina & Patel, 
1995). However, Sale and Randle (1982) documented that in rat heart, the complex was 
dephosphorylated in the order of site 2 > site 1 = site 3. Using in vitro preparations of 
purified enzymes, Kolobova et al. (2001) also showed that the two isoforms of PDP 
respond at different rates when the complex is phosphorylated by different isoforms of 
PDK. It has been shown that both isoforms easily dephosphorylate PDH, at about the 
same rate, when it has been phosphorylated by PDK2. Both enzymes also display the 
lowest rates of dephosphorylation when PDKI has phosphorylated the complex, 
however, PDPl dephosphorylates the complex under these conditions at a rate that is 
approximately 3-fold greater than PDP2. Lastly, there is little difference in reactivating 
the complex following PDK3 and PDK4 phosphorylation, but again PDPl is faster than 
PDP2 (Kolobova et aI., 2001). In a similar study, it was demonstrated that both isoforms 
of PDP dephosphorylated PDH at site 2 faster than site I (PDPl: IS-times, PDP2: 10-
times) and site 3 two-times faster than site 1 (order: site 2> site 3> site 1; Karpova et aI., 
2003). It was also found that the dephosphorylation of site 1 by PDP 1 did not require 
dephosphorylation of sites 2 or 3 (nor did phosphorylation of site 3 affect the 
dephosphorylation of site 2). This would suggest that PDPl follows a random 
dephosphorylation sequence as phosphorylation of additional sites does not affect the 
ability to dephosphorylate individual sites (Karpova et aI., 2003). 
The ability ofPDP2 to dephosphorylate site 2 also seems to be unaffected by site 
3 phosphorylation, indicating that dephosphorylation of these sites is also random. 
However, phosphorylation of sites 2 or 3 causes the dephosphorylation rate of site 1 by 
PDP2 to be approximately two times slower than the dephosphorylation of site 1 alone. 
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This would indicate that, unlike PDP 1, PDP2 does not follow a random 
dephosphorylation sequence as sites 2 and 3 must be dephosphorylated before site 1 can 
be dephosphorylated. This finding for PDP2 would translate into an increased difficulty 
to activate PDH in tissues expressing predominantly this isoform, especially under 
circumstances causing multi-site phosphorylation ofPDH (ex. starvation/diabetes, high-
fat diets; Karpova et aI., 2003). 
Adaptive Regulation of PDH 
Changes in Response to Nutritional Perturbations 
PDK 
Ofthe two regulatory enzymes, PDK has received the greater attention in 
literature to date. There have been many studies investigating the effect of diet on 
adaptive changes to PDK activity and expression and PDHa activity. Thus far, research 
has shown that with a decrease in carbohydrate supply to the cell, there is an increase in 
PDK activity, causing a decrease in PDHa activity (as reviewed by Peters & LeBlanc, 
2004). Fuller & Randle (1984) demonstrated that the skeletal muscle of rats that were 
starved for 48hrs, or were induced with type I diabetes via pancreatic p-cell damaging 
drugs, had a significant decrease in the portion of complex that was in the active form 
compared to controls. Further investigation in this study revealed that PDK activity was 
increased 2-3-fold with 48hr starvation or drug-induced diabetes. More recent research 
has investigated the protein content ofPDK following other nutritional perturbations. 
These studies have shown that PDK2 is increased in rat liver, kidney, and mammary 
19 
gland (Wu et aI., 2000), as well as rat anterior tibialis (Sugden et aI., 2000) and liver 
(Sugden et aI., 1998) following starvation. High-fat feeding has also been found to 
increase PDK2 expression in liver (Sugden et aI., 1998), as well as increasing PDK4 
expression in the soleus and anterior tibialis of rats (Holness et aI., 2000). Research has 
also shown that the increased PDK4 expression that is induced by starvation is capable of 
being reversed with refeeding for 4hrs in the skeletal muscle of rats (Sugden et aI., 2000). 
In human skeletal muscle, Peters et al. (2001 b) observed that a high-fat/low-
carbohydrate diet caused a continual increase in PDK activity throughout the 3 day 
period. In looking at the protein content of the isoforms, they found that after just one 
day on the diet, PDK4 content increased by an average of70% and remained increased 
throughout the rest of the diet period, but PDK2 was unaffected by the intervention 
(Peters et aI., 2001 b). Because PDK4 is seen as being the most responsive to changes in 
mitochondrial/lipid state, it has been termed the "'lipid status'-responsive PDK isoform" 
(Sugden et aI., 2001) 
There has been the suggestion that this increase in PDK activity and expression 
and decrease in PDHa activity when a diet is increased in fat is likely due to a decrease in 
carbohydrates rather than a result ofthe fat (Turvey et aI., 2004). Turveyet al. (2004) 
conducted a study in which they manipulated the composition of the dietary fat in 
humans, with the finding that a high-fat diet that is composed of 15% of fat being n-3 
fatty acids leads to an attenuated increase in PDK activity in skeletal muscle (Turvey et 
aI., 2004). This finding gives support to the idea that the increased PDK activity and 
expression following an increase in dietary fat is not solely the result of decreased 
carbohydrate intake, but is also influenced by the amount and composition of the fat that 
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is present in the diet. Related to this, Bradley et al. (2008) also found that the short-tenn 
consumption of differential dietary fats lead to differences in PDHa activities and fat 
oxidation during moderate intensity exercise. It was found that fat-loading with n-6 fatty 
acids over 5 hours attenuated the increase in PDHa activity at the onset of exercise in 
comparison to saturated fatty acids. This, however, was not accompanied by a change in 
PDK activity, which is likely due to the short duration (5hrs) of fat consumption, with the 
attenuated increase in PDHa activity in the n-6 fatty acid consumption likely due to 
changes in the mitochondrial effectors ofPDK. This shows that there is a time course for 
the adaptive change in PDK activity and expression. 
PDP 
The explanation for the above decrease inPDHa activity and carbohydrate 
oxidation with dietary manipulations focussed on the increase PDK activity and content. 
However, it stands to reason that this same decrease in PDHa activity could be attributed 
to a decrease in PDP activity or content (Huang et aI., 2003). In one of the first studies to 
look at the effect of nutritional state on PDP activity, Fuller & Randle (1984) found that 
48hr starvation or drug-induced diabetes rats had no change in PDP activity in rat hind-
limb skeletal muscle. However, more recently a study by LeBlanc et al. (2007), observed 
a decrease in PDP activity and PDP2 protein content after 48hrs of food deprivation in rat 
skeletal muscle. These contradictory findings, though, are suspected to be a result of 
differences in individual fibre type, as Fuller & Randle (1984) studied mixed hind-limb, 
while LeBlanc et al (2007) studied the individual fibre types of soleus (type I), red 
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gastrocnemius (type IIa) and white gastrocnemius (type lIb). Similarly, it has also been 
found that PDP activity decreases in response to starvation in rat mammary gland and 
kidney (Baxter & Coore, 1979, Cockburn & Coore, 1995). Huang et al. (2003) 
investigated the effect of 48hr starvation or drug-induced diabetes on PDP activity and 
isofonn expression in rat heart and kidney. They found that starvation and diabetes 
reduced PDP2 protein in these tissues and that refeeding and insulin treatment returned 
PDP2 levels to nonnal. These results also demonstrated that starvation and drug-induced 
diabetes had no effect on PDP} content in rat heart, although PDPI decreased in kidney 
tissue with starvation and was partially restored with refeeding. Overall, there was a 
decrease in PDP activity with starvation or drug-induced diabetes in these tissues, which 
was reversed with refeeding or insulin-treatment respectively (Huang et al., 2003). 
However, to date there have been no studies examining PDP activity in human skeletal 
muscle. 
Changes in Response to Exercise Training 
PDK 
In recent years, research has begun to focus on the adaptive changes that occur to 
PDH as a result of training. Numerous studies have also investigated the effects of 
prolonged exercise training on total PDH activity (PDHt) and PDHa activities with the 
results showing no increase in PDHt in rats (Brozinick et al., 1988, Nakai et al., 2002, 
Nakai et al., 1999). However, there were increases in PDHt following exercise training 
in diabetic rats (Nakai et al., 2002). PDHa activity has been shown to have mixed results 
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following exercise training with some finding a decrease in activity in rats at rest (Nakai 
et aI., 1999, Nakai et aI., 2002), as well as in humans at rest and after 15min of exercise 
(LeBlanc et aI., 2004a). However, other studies have found an increase in activity in rats 
(Brozinick et aI., 1988), diabetic rats at rest (Nakai et aI., 2002) and humans at rest and 
during exercise (Burgomaster et aI., 2006, Ward et aI., 1986), while Putman et al. (1998) 
found no change in PDHa after 7 days of submaxima} cycle ergometer training in humans 
at rest or during exercise. This large discrepancy in results can most likely be attributed 
to species differences and the various durations of the training (7 days to 5 months). In 
addition, studies differed in the training methods employed: sprint interval training 
(Burgomaster et aI., 2006), strength training (Ward et aI., 1986), or cycling/running 
(Brozinick et aI., 1988, LeBlanc et aI., 2004a, Nakai et ai., 2002, Nakai et aI., 1999, 
Putman et aI., 1998). It has been suggested that these differences in training methods 
may be of particular importance as the increases in PDHa observed by Burgomaster et al. 
(2006) and Ward et aI. (1986) may be a result of increased sensitivity of PDP to calcium 
with sprint interval training (Burgomaster et aI., 2006) or training that resembles sprint 
interval training (Ward et aI., 1986). 
In a more in depth study in human subjects, 8wks of aerobic training lead to a 
31 % increase in PDHt activity which was accompanied by a 1.3-fold increase in the 
protein content of only the E 1 a subunit, with no significant change in E2 or E3BP. There 
was also a doubling ofPDK activity which was accompanied by a l.3-fold increase in 
PDK2 content, while PDKI and PDK4 were unaltered (LeBlanc et aI., 2004b). This 
increase in PDK2 content is of particular importance because it is the isoform that is most 
strongly inhibited by pyruvate and ADP (Bowker-Kinley et aI., 1998, Gudi et aI., 1995), 
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which both increase during exercise. Therefore, this has lead to the suggestion that 
PDK2 may be the "'energy status'-responsive PDK isoform" (LeBlanc et al., 2004b). The 
increased content of the E 1 a subunit is also of importance as this is the subunit that 
makes the PDH reaction irreversible, as well as being the regulatory subunit that has the 
three phosphorylation sites (Patel & Korotchkina, 200 1 b). However, despite the increase 
in maximal capacity for oxidizing carbohydrates (via increased PDHt activity and EI a 
protein content), there is an overall decrease in PDHa activity when exercising at 
submaximallevels following 7 weeks of aerobic exercise training (LeBlanc et al., 2004a). 
Seven weeks of aerobic exercise training also leads to a decrease in pyruvate 
accumulation (LeBlanc et al., 2004a), which would mean a decreased inhibition ofPDK2 
(the isoform that is most sensitive to pyruvate inhibition), and therefore, increased 
phosphorylation ofPDH during this submaximal exercise. Therefore, the coordinated 
increases in both PDHt and PDK activities with aerobic training allows for increased 
capacity to utilize carbohydrates when needed during maximal exercise, but also allows 
for conservation of carbohydrates during submaximal exercise when they are not needed 
(LeBlanc et al., 2004b). 
PDP 
In contrast to the reciprocal changes seen between PDK and PDP with nutritional 
manipulations, training adaptations do not appear to cause opposing changes in these 
enzymes. LeBlanc et al. (2008) found that following 8 weeks of endurance training in 
lean and obese Zucker rats, there was an increase in PDP activity in all skeletal muscles 
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examined (RG; white gastrocnemius, WG; and soleus) of obese rats, but not lean rats. 
However, there was a trend toward an increase in PDP activity in the RG and soleus of 
lean rats suggesting that a greater potential for increase in PDP activity is needed for the 
observed increase in PDP activity to reach significance. This greater potential for an 
increase in activity was seen in the obese rats as they had lower PDP activity values 
before training compared to lean rats, thereby allowing for greater gains to be made in 
this group with training. Training also caused a significant increase in the expression of 
PDP} in the soleus and RG of obese rats and the soleus oflean rats, with no change in the 
expression ofPDP2. This is of particular significance as PDPl is the calcium-sensitive 
isoform of PDP, and therefore, when Ca2+ is released for muscle contraction during 
exercise, increased levels of PDP 1 would allow for enhanced carbohydrate oxidation 
during maximal exercise by overriding PDK activity and activating PDH. 
Summary of Adaptive Changes 
To date, there has been a plethora of research investigating the adaptive changes 
that PDH undergoes in response to different perturbations. The most commonly 
investigated of these perturbations is that of a change in nutritional state. Research has 
shown that an increase in dietary fat for a prolonged time period, as well as starvation, or 
diabetes leads to an adaptive increase in PDK activity. Specifically this increase in PDK 
activity is accompanied by an upregulation in the expression of the PDK4 isoform, and in 
some instances in various rat tissues, the PDK2 isoform. Studies investigating the same 
nutritional changes on PDP, have found that there is a decrease in PDP activity, with a 
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specific decrease in the content of the PDP2 isoform. With this increase in PDK activity 
and decrease in PDP activity there is an overall decrease in PDHa activity, allowing for 
the conservation of carbohydrates during these situations in which carbohydrates are in 
limited supply. 
During exercise there is an increased need for energy in the working muscles, 
with this increased demand leading to an increased need for carbohydrate oxidation. This 
increased demand for carbohydrate also requires an increased regulation so as to conserve 
carbohydrate when energy demand is not as high, and fat is capable of meeting the body's 
energy needs. Studies on aerobic training have shown that there is an increased protein 
expression of the regulatory Ela subunit ofPDH, with no change in the other subunits, 
allowing for a greater maximal flux through PDH. However, there is also an increase in 
PDK activity as a result of training, with a specific increase in the protein expression of 
the PDK2 isoform. In obese rats, and to a certain extent in lean rats, aerobic training has 
also been seen to cause an increase in maximal PDP activity, which is accompanied by an 
increase in PDP 1 protein expression, with these changes being most evident in obese rats. 
At present, however, no study has investigated ifthere is also a change in PDP activity or 
isoform expression in humans as a result of exercise training. 
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CHAPTER 2: 
STATEMENT OF THE PROBLEM 
With the observed coordinate regulation ofPDK and PDP in response to dietary 
perturbations affecting the PDH complex, it would also be expected that such coordinate 
changes would also exist with endurance training adaptations. To date, the only study 
that has looked at the effect of training on the PDH regulatory proteins in humans has 
focused solely on PDK (LeBlanc et aI., 2004b), with no investigation of changes in PDP 
activity in humans. As well, the only studies investigating the adaptive regulation of PDP 
as a result of dietary (LeBlanc et aI., 2007) and training (LeBlanc et aI., 2008) 
manipulations have been done in rats. With the finding that PDP activity and expression 
are increased with training in rat skeletal muscle, it should be determined if there is a 
similar increase in PDP activity and expression in humans, which would balance the 
increase in PDK activity and expression seen with exercise training. 
Purpose 
The purposes of this cross-sectional study are: 1) to determine if it is possible to 
measure PDP activity in human skeletal muscle; and 2) to investigate ifthere are 
differences in PDP activity and expression between subjects with different aerobic 
capacities. 
27 
HYPOTHESES 
a) It is expected that PDP activity in skeletal muscle will be positively correlated with 
aerobic capacity, so as to offset the increase in PDK activity that has been seen with 
longitudinal aerobic exercise training studies. 
b) PDP 1 content is expected to increase with aerobic capacity because it is the 
predominant isoform in skeletal muscle, which is the tissue that is responsible for 
changes occurring with training (e.g. aerobic capacity). Due to the minimal content of 
PDP2 in skeleta-l muscle, and its insensitivity toward calcium (which causes muscle 
contraction and thereby, training changes), it would be expected that no change in its 
content would occur with aerobic capacity. However, as no human antibody is 
commercially available at present for PDP2, it will not be measured in this study. 
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CHAPTER 3: 
METHODS 
Subjects 
Male (n=18) and female (n=12) subjects volunteered for this study and were 
recruited via poster advertisements at McMaster University (Hamilton, ON). All subjects 
were healthy, non-smokers and non-diabetic, and were free to withdraw at any point 
during the trial without penalty. For their participation time in this study, subjects were 
reimbursed with $100. This research project was given ethics approval from both 
McMaster University (05-250) and Brock University (05-083). 
Experimental Protocol 
Subjects first came in for an interview during which time the study was explained 
to them, and they filled out a questionnaire regarding current health status and gave a 
detailed description of their physical activity levels over the past few months. Subjects 
then signed a consent form to participate in the study and were given an information form 
regarding the study. A dietary analysis was also done for a typical three day period to 
record habitual caloric intake ofthe subject. Once consent was given to participate in the 
study, a V02peak test was conducted on an electromagnetically-braked cycle ergometer 
(Lode Excalibur, Quinton Instruments, Seattle, W A, USA) using a metabolic 
measurement system (Quinton Q-Plex 2, Quinton Instruments, Seattle, W A, USA) 
following a protocol with incremental workloads. Subjects began the V02peak test by 
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cycling against a resistance of SOW, with the resistance increased to 100W after Imin and 
increased by 2SW every minute after that until the subjects reached exhaustion (unable to 
maintain 80rpm). At least a week later subjects reported back to have two resting muscle 
biopsies done in the vastus Iateralis with the first immediately placed in buffer at 4°C for 
mitochondrial extraction and the second immediately frozen in liquid nitrogen for later 
analysis of citrate synthase activity and Western blotting for specific proteins. Subjects 
refrained from alcohol, caffeine, and exercise for at least 24hrs before the biopsies and 
consumed their habitual diet in that time period. Their last habitual meal was consumed 
at least 3hrs before the biopsies were done. 
Mitochondrial Extraction 
Mitochondria were isolated from the first muscle biopsy by differential 
centrifugation, following a method that targets mostly sub-sarcolemmal mitochondria, as 
originally described by Makinen and Lee (1968) and modified by Jackman and Willis 
(1996), and has been used previously (LeBlanc et aI., 2004b, LeBlanc et aI., 2007, 
LeBlanc et aI., 2008, Peters et aI., 1998 and 200 1 b). Briefly, ~ 7 Smg muscle was minced 
and homogenized on ice by hand in 20 volumes of solution 1 (100mM KCI, 40mM Tris 
HCl, 10mM Tris Base, SmM MgS04, SmM Na2EDTA, ImM ATP, pH 7.S). The sample 
was then centrifuged at 700g for 10min at 4°C to pellet out the contractile proteins, large 
membranes, and other cellular debris. The supernatant was retained and spun at 14,000g 
for 10min at 4°C to pellet out the mitochondria after which the supernatant was discarded 
and the pellet resuspended in 10 volumes of solution 2 (1 OOmM KCI, 40mM Tris HCI, 
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10mM Tris Base, ImM MgS04, O.lmM Na2EDTA, 0.25mM ATP, 1 % BSA) and 
centrifuged at 7000g for 10min at 4°C. The supernatant was drawn off and discarded and 
the pellet was resuspended in solution 3 (same as solution 2, but with BSA omitted) and 
centrifuged at 7000g for 10min at 4°C. The supernatant was drawn off and discarded and 
the pellet was resuspended in a 1: 1 weight/volume ratio (1 mg/IIll) of Sucrose and 
Mannitol (S&M) buffer (220mM Sucrose, 70mM Mannitol, 10mM Tris HCI, O.lmM 
Na2EDTA, pH 7.4) for use in PDP activity analysis. A 5uI aliquot ofthis suspension was 
added to 100ul of S&M for measurement of mitochondrial total suspension citrate 
synthase activity (CSts) to determine mitochondrial recovery. Mitochondria for PDP and 
CSts activity were stored at -80°C. 
Citrate Synthase 
A piece (~ 1 Omg) of muscle was chipped from the frozen biopsy and homogenized 
on ice in 100 volumes of homogenizing buffer (O.IM KH2P04, 0.05% BSA, pH 7.3) and 
freeze/thawed twice using liquid nitrogen. Citrate synthase activity for the homogenate 
(CShomogenate) was determined using a spectrophotometer (Biochrom, Cambridge, 
England) and measuring the formation ofDTNB-CoA from dithiobis-2-nitrobenzoate 
(DTNB) and CoASH at 412nm. This reaction is buffered by 150ul of 100mM Tris buffer 
(PH 8.3), and with the addition of25ul of ImM DTNB, 15ul of lOmM oxaloacetate, 40ul 
of 3mM acetyl CoA, 10uI of Triton-X, and 10ui of sample (either muscle homogenate or 
mitochondrial total suspension), the following reactions occur: 
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Oxaloacetate + Acetyl CoA ------ citrate synthase -------> Citrate + CoASH 
CoASH + DTNB -------------> DTNB-CoA 
This protocol was also followed to analyze the CS activity in mitochondrial TS (CSts) for 
use in calculating mitochondrial recovery (Srere, 1969). 
% mitochondria recovery = CStJCShomogenate x 100 
Protein Concentration 
Protein concentration of samples was detennined by following the standard 
procedure for the Bio-Rad protein assay (Bio-Rad Laboratories, CA, USA) with minor 
modifications. Briefly, samples were diluted 10-fold with deionized water and 10ul was 
added to a microtiter plate in duplicate along with several dilutions of a BSA protein 
standard. A 5min incubation at room temp was then done following the addition of 200ul 
of diluted Bio-Rad Dye Reagent and absorbance was read at 595 nm using a multi-
detection microplate reader (Bio-Tek Instruments, VT, USA). 
PDP Activity Assay 
Pyruvate dehydrogenase phosphatase (PDP) activity was detennined using the 
nonradioactive phosphatase assay system from Promega (Madison, WI) and a synthetic 
peptide substrate from New England Peptide (Gardner, MA) as previously described 
(LeBlanc et aI., 2007, Huang et aI., 2003, Caruso et aI., 2001) with minor modifications. 
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Briefly, mitochondria were diluted with S&M to a final protein concentration of2uglul 
and a total volume of 30ul. Samples were then freeze/thawed three times in liquid 
nitrogen to disrupt mitochondrial membranes and centrifuged at 21,000g for Ihr at 4°C to 
pellet out large protein and other insoluble materials, leaving PDP in the supernatant. 
The supernatant was further purified through Sephadex G-2S in spin columns, which 
were centrifuged at 600g for Smin at 4°C, to remove excess inorganic phosphate from the 
supernatant. The spin columns were prepared approximately Ihr before the addition of 
the sample by equilibration with 10mi Sephadex G-2S storage buffer (10mM Tris Base, 
ImM EDTA, 0.02% Sodium Azide, pH 7.5) followed by centrifugation at 600g for Smin 
at 4°C to remove the remaining buffer from the column. The prepared sample (SuI) was 
then added to a plate well containing 10uI reaction buffer (2S0mM Imidazole, ImM 
EGTA, 2SmM MgC}z, 0.1% ~-Mercaptoethanol, O.Smglml BSA, pH 7.2), luI 
Phosphatase Inhibitor cocktail (Sigma, St. Louis, MO, USA) to inhibit other 
phosphatases (alkaline phosphatases, protein phosphatases 1 and 2A), brought to a total 
volume of SOul with phosphate-free water and incubated at 37°C for 10min to equilibrate 
the wells. The reaction was started with the addition of 13ul 1.SmM phosphopeptide and 
was incubated at 37°C for 30min during which time PDP would remove inorganic 
phosphate (Pi) from the peptide. The reaction was stopped by adding SOul of molybdate 
dye to each well with a 30min incubation at room temperature to allow colour 
development. Optical density of the plate was read by measuring light absorbance at 
600nm. Activity was determined through the use of a standard of 0, 0.1, 0.2, 0.5, 1.0, and 
2.0nmols of inorganic phosphate (Pi) that was set up on the same plate. A standard curve 
regression was used to determine the amount of Pi produced by the mitochondrial 
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sample. Samples and standards were done in duplicate with the average of the duplicates 
taken as the accepted activity value. Activity is expressed in nmols Pi/min/mg 
mitochondrial protein and nmols/min/g wet tissue weight. Activity per gram wet tissue 
weight was calculated using % mitochondrial recovery in the following formulas: 
nmols/min/1l1 mitochondrial solution = nmols/min -;- 5111 (amount added to well) 
nmols/min/1l1 extracted mitochondrial solution = nmols/min/1l1 mitochondrial 
solution x mitochondrial dilution 
nmols/min/g wet tissue wt = nmols/min/1l1 extracted mitochondrial solution -;- % 
mitochondrial recovery x 1000 
Western Blotting 
Protein content was determined following the methods of LeBlanc et al (2007). A 
piece (~ 1 Omg) of muscle was chipped from the frozen biopsy and homogenized on ice in 
100 volumes of homogenizing buffer (250mM Sucrose, 100mM KCI, 2mM EDTA, pH 
6.8) which also contained a protease inhibitor cocktail (Complete Mini EDTA-free, 
Roche, Laval, QC). Samples were diluted to a final concentration of 1 ug/ul in 1 M DTT 
(10% of total volume), and 5x sample buffer (250mM Tris HCI, 10% SDS, 0.5% 
bromophenol blue, 50% glycerol). Samples were solubilized by boiling for 5min and 
cooled on ice for 5min. Standard SDS-PAGE electrophoresis was done using 4% 
stacking and 10% (or 12% for COX-IV blots) separating gels on 5ug of sample (or 2.5ug 
for PDP 1 blots) which was run at 120V for 90min. Proteins were transferred from the gel 
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to a polyvinylidene fluoride (Immobilon-P, Millipore, Bedford, MA) (0.45um pore size) 
using the Mini Trans-Blot System (Bio-Rad Laboratories, CA, USA) and a transfer buffer 
(25mM Tris Base, 192mM glycine, 1 giL SDS, and 20% methanol) and were run at lOOV 
for 60min. Membranes were blocked for Ihr in TBST (200mM Tris Base, I.37M NaCl, 
38mllM HCI/L TBST, 0.1% Tween 20, pH 7.5) with 5% non-fat dry milk to block all 
non-specific binding sites. Membranes were then incubated overnight at 4°C in lOmlof 
blocking solution (TBST with 5% skim milk) with a polyclonal antibody against PDP} 
(diluted 1 :2000; a kind gift from Drs. Brian Robinson and Mary Maj, Genetics and 
Genome Biology, SickKids Hospital, Toronto, ON), or monoclonal antibodies against 
PDH Ela (diluted 1 :5000; #A-21323), PDH E2 (diluted 1 :5000; #A-21325), COX-IV 
(diluted 1:1000; #A-21348; Molecular Probes, OR, USA), and actin (diluted 1:5000; 
#612656; BD Biosciences, Mississauga, ON). Membranes were washed 3-4 times in 
TBST 5-15min and were incubated at 4°C for 2hrs in 10ml blocking solution with either 
goat anti-mouse IgG (diluted 1 :5000; #A4416; peroxidase conjugated, Sigma, ON) or 
goat anti-rabbit IgG (diluted 1: 1 0,000; sc-2004; Santa Cruz Biotechnology, CA, USA). 
Membranes were washed 3 times for 5min in TBST and chemiluminescent substrate 
(ChemiGlow West, Alpha Innotech, CA, USA) was added for visualization using a 
Fluorchem 5500 imaging station (Alpha Innotech, CA, USA). Membranes were stored 
between blotting paper at 4°C, after being soaked in methanol and air dried, for 
reprobing. Optimization was done on the PDPI antibody by loading 2.5, 5, and 1 O/lg of 
protein and diluting the primary antibody 1: 1 000 and 1 :2000. To reprobe for different 
proteins, membranes were washed for 15min in TBST, washed 5-1 Omin in Restore Plus 
Western Blot stripping buffer (Pierce Biotechnology, IL, USA) to remove previous 
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antibodies, followed by a lOmin wash in TBST and 1hr block before adding the primary 
antibody as outlined above. Detection of the membrane revealed that the previous 
antibody had been stripped off. PDPl protein was always determined on an original 
membrane, while E 1 a, E2, and COX IV were either on original or repro bed membranes. 
All protein values were normalized to actin to ensure equal10ading (with the exception of 
E 1 a, which could not be reprobed properly for actin due to their near identical molecular 
weights). Blot density was quantified using the National Institute of Health ImageJ 
software (downloaded from: http://rsb.info.nih.gov/ij/) and is expressed in arbitrary 
densitometry units. Due to the large number of subjects in this study, several separate 
membranes were required for protein analysis. To compensate for variations between the 
membranes, 6-7 subjects were repeated across the membranes which allowed for 
membranes to be expressed relative to each other by taking the average difference of 
these subjects between the membranes. 
Data Analysis and Statistics 
Differences between males and females were analyzed with independent t-tests 
and a p-value < 0.05 was accepted as significant. All other comparisons were done 
through Pearson's correlation coefficients with a p-value < 0.05 for the slope accepted as 
significant and a p-value < 0.10 accepted as indicating a trend. 
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CHAPTER 4: 
RESULTS 
Subject Characteristics 
Subjects had V02peak values ranging from 30.0 to 64.5ml/kg/min (2.10 to 
5.35L1min) and citrate synthase (CS) measures ranging from 7.04 to 32.30~mols/min/g 
wet tissue wt (3.53 to 11.54~mols/min/mg mitochondrial protein; see Figure 4.1 for 
representative histograms of aerobic capacity). As expected, males were significantly 
taller and heavier than females, as well as having significantly higher relative and 
absolute V02peak scores (Table 4.1). No other significant differences were found between 
males and females on any study measures (data not shown). 
Table 4.1. Subject characteristics and aerobic capacity of males and females. 
Variable Males (n=18) Females (n=12) 
Age (yrs) 24.2 ± 0.68 22.6 ± 1.24 
Height (m) 1.82 ± 0.01 1.68 ± 0.02* 
Weight (kg) 81.2 ± 2.18 66.6 ± 2.22* 
BMI 25 ±0.6 23 ± 0.6 
V02peak (ml/kg/min) 48.0 ± 1.71 40 ± 1.46* 
V02peak (L/min) 3.89 ± 0.15 2.67 ± 0.11* 
CS (Ilmols/min/g wet tissue) 20.1 ± 1.14 16.4 ± 1.54 
CS (Ilmols/min/mg mitochondrial protein) 7.94 ± 0.45 6.87 ± 0.49 
PDP activity (nmols/min/mg mitochondrial protein) 0.526 ± 0.073 0.518 ± 0.097 
PDP activity (nmols/min/g wet tissue wt) 7.36 ± 1.49 5.73 ± 1.15 
PDP1 protein content (arbitrary units) 4206.3 ± 248.3 4133.4 ± 517.1 
Values are means ± SE. BMI, body mass index; CS, citrate synthase. Significantly 
different from males: * p< .01. 
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Figure 4.1. Representative histograms of the range of aerobic capacities in male and 
female subjects for relative (A) and absolute (B) V02peak, and CS activity per g wet tissue 
wt (C) and per mg mitochondrial protein (D). 
A significant positive correlation was found between V02peak values against CS 
activity for all subjects together (p< 0.05) and for male subjects alone (p< 0.01) (data not 
shown). However, no significant correlations were found within females alone between 
V02peak and CS activity (data not shown). 
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Dietary Analysis 
Analysis of a self-reported 3-day dietary chart revealed an average consumption 
of2285 ± 786 and 2540 ± 480kcal with a range of 1075 to 3301kcal and 1754 to 
3201kcal for males (n= 15) and females (n= 8) respectively. The composition ofthese 
diets was: 51.0 ± 7.2% (range: 40.7 to 61.3%) and 48.3 ± 7.9% (range: 33.0 to 56.3%) 
carbohydrate; 17.5 ± 5.2% (range: 10.0 to 27.3%) and 18.8 ± 5.2% (range: 13.0 to 27.3%) 
protein; and 30.6 ± 4.9% (range: 23.0 to 42.0%) and 32.3 ± 6.8% (range: 26.0 to 46.3%) 
fat for males and females respectively. Values are means ± SD. 
PDP Activity 
Correlations between PDP activity and aerobic capacity variables are shown in 
Table 4.2. A strong positive correlation was found in males between PDP activity and 
absolute V02peak (r= 0.65; p< 0.01); as well as CS activity (per g wet tissue wt; r= 0.63; 
p< 0.01 and per mg mitochondrial protein; r= 0.71; p< 0.01), with a trend towards a 
positive correlation for relative V02peak (r= 0.44; p= 0.08). However, unlike the males, 
females displayed only a trend towards a positive correlation with absolute V02peak (r= 
0.55; p= 0.10), and no significant correlations found between other aerobic variables and 
PDP activity. However, despite the differences seen in the way PDP activity in males 
and females correlates to aerobic capacity (Table 4.2), there was no significant difference 
in total PDP activity values between males (see Table 4.1). 
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Table 4.2. Correlations of PDP activity against V02peak and CS measurements. 
VARIABLE PDP activity 
mg mitochondrial protein g wet tissue wt 
r R2 p r R2 p 
MALES (N= 17) 
V02peak (ml/kg/min) 0.44 0.19 0.08 0.53 0.28 0.03 
V02peak (L/min) 0.65 0.42 <0.01 0.65 Q& <0.01 
CS (I-lmols/min/g wet tissue wt) 0.63 0.39 <0.01 0.80 0.63 <0.01 
CS (I-lmols/min/mg mitochondrial protein) 0.71 0.51 <0.01 0.77 0.59 <0.01 
FEMALES (N= 10) 
V02peak (ml/kg/min) 0.41 0.17 0.23 0.46 0.21 0.18 
V02peak (L/min) 0.55 0.30 0.10 0.52 0.27 0.13 
CS (I-lmols/min/g wet tissue wt) 0.37 0.13 0.30 0.03 <0.01 0.94 
CS (I-lmols/min/mg mitochondrial protein) 0.23 0.05 0.53 0.12 0.01 0.74 
ALL (N= 27) 
V02peak (ml/kg/min) 0.37 0.14 0.05 0.50 0.25 <0.01 
V02peak (L/min) W. 0.19 0.03 0.50 0.25 <0.01 
CS (I-lmols/min/g wet tissue wt) 0.29 0.08 0.15 0.63 0.39 <0.01 
CS (I-lmols/min/mg mitochondrial protein) 0.41 0.17 0.04 0.64 0.41 <0.01 
Significant values are underlined in bold italics; trends are shown in bold. CS, citrate synthase; PDP, pyruvate dehydrogenase 
phosphatase. 
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Figure 4.2. Scatterplot of the correlation between CS activity and PDP activity relative to 
mitochondrial protein in males (solid trendline; y = O.lx - 0.1988, R2 = 0.51, P < 0.01) 
and females (dashed trendline; y = 0.0443x + 0.8309, R2 = 0.05, P = 0.53). CS, citrate 
synthase; PDP, pyruvate dehydrogenase phosphatase. 
When PDP activity was calculated to the whole muscle (per gram wet tissue 
weight), there were strong positive correlations found with all aerobic capacity variables 
(CS and V02peak) for all subjects combined and for males alone. However, no 
correlations were seen for any aerobic variables against PDP activity in females. 
PDP1Is%rm and Mitochondrial Protein Contents 
Significant positive correlations and trends were found between the aerobic 
variables (V02peak and CS) and protein content for all subjects combined and males alone 
(Tables 4.3 & 4.4). In particular, males demonstrated a significant positive correlation 
between PDP! protein content and PDP activity (r= 0.47; p= 0.05; Figure 4.4). Females 
showed very few correlations of protein content with aerobic capacity and PDP activity 
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(Table 4.5). However, significant positive correlations were seen between CS activity 
(per g wet tissue wt) and both Ela (r= 0.60; p= 0.05) and COX IV (r= 0.60; p= 0.05). 
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Table 4.3. PDP 1, E 1 a, E2, and COX IV protein content against V02peak, CS, and PDP activity measurements for all subjects (N= 29). 
PROTEIN PDPl Ela E2 COX IV 
slope p slope p slope p slope p 
V02peak (ml/kg/min) 0.0086 0.08 0.0097 0.10 0.0041 0.26 0.0125 <0.01 
V02peak (L/min) 0.0567 0.22 0.0407 0.46 0.0215 0.53 0.0915 0.03 
CS (Ilmols/min/g wet tissue) 0.0179 <0.01 0.0235 <0.01 0.0085 0.05 0.0167 <0.01 
CS (Ilmols/min/mg mitochondrial protein) 0.0481 <0.01 0.0594 <0.01 0.0224 0.08 0.0624 <0.01 
PDP activity (nmols Pi/min/mg mito protein) 0.1581 0.24 0.1459 0.39 0.1752 0.09 0.1984 0.11 
PDP activity (nmols Pi/min/g wet tissue) 13.718 0.05 16.85 0.05 9.5368 0.08 12.638 0.05 
Values are p values and slopes from Pearson's correlation coefficients. Significant values are underlined in bold italics; trends are 
shown in bold. CS, citrate synthase; PDP, pyruvate dehydrogenase phosphatase. 
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Table 4.4. PDPl, Ela, E2, and COX IV protein content against V02peak, CS, and PDP activity measurements for male subjects (N= 
18). 
PROTEIN PDPl Ela E2 COX IV 
slope p slope p slope p slope p 
V02peak (ml/kg/min) 0.008 0.13 0.0205 <0.01 0.0104 0.01 0.0157 <0.01 
V02peak (L/min) 0.1228 0.04 0.1829 0.05 0.105 0.04 0.1894 <0.01 
CS (I-lmols/min/g wet tissue) 0.0178 <0.01 0.026 <0.01 0.0128 <0.01 0.0172 <0.01 
CS (I-lmols/min/mg mitochondrial protein) 0.0377 0.02 0.0573 0.02 0.0358 <0.01 0.062 <0.01 
PDP activity (nmols Pi/min/mg mito protein) 0.2346 0.05 0.1922 0.36 0.1136 0.31 0.2218 0.11 
PDP activity (nmols Pi/min/g wet tissue) 13.974 0.02 18.976 0.05 8.4738 0.11 11.831 0.08 
Values are p values and slopes from Pearson's correlation coefficients. Significant values are underlined in bold italics; trends are 
shown in bold. CS, citrate synthase; PDP, pyruvate dehydrogenase phosphatase. 
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Table 4.5. PDP!, Ela, E2, and COX IV protein content against V02peab CS, and PDP activity measurements for female subjects (N= 
11 ). 
PROTEIN PDP1 E1a E2 COX IV 
slope p slope p slope p slope p 
VOzpeak (mljkg/min) 0.0292 0.08 0.0026 0.87 -0.0048 0.68 0.0181 0.14 
VOzpeak (L/min) 0.4089 0.19 0.0739 0.79 -0.0724 0.73 0.2498 0.28 
CS (I-lmols/min/g wet tissue) 0.0189 0.24 0.0192 0.15 -0.0018 0.87 0.0149 0.19 
CS (I-lmols/min/mg mitochondrial protein) 0.0827 0.07 0.0759 0.05 -0.013 0.68 0.0636 0.05 
PDP activity (nmols Pi/min/mg mito protein) 0.0142 0.97 0.0848 0.81 .375 0.12 .1322 0.65 
PDP activity (nmols Pi/min/g wet tissue) 19.211 0.50 11.337 0.67 21.057 0.28 19.071 0.39 
Values are p values and slopes from Pearson's correlation coefficients. Significant values are underlined in bold italics; trends are 
shown in bold. CS, citrate synthase; PDP, pyruvate dehydrogenase phosphatase. 
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Figure 4.3. Scatterplot ofthe correlation between CS activity and PDPI protein content in 
males (solid trendline; y = 0.0178x + 0.3217, R2 = 0.57, p < 0.001) and females (dashed 
trendline; y = 0.0189x + 0.3281, R2 = 0.149, P = 0.24). CS, citrate synthase; PDP, 
pyruvate dehyrogenase phosphatase. 
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Figure 4.4. Scatterplot of the correlation between PDP activity and PDP1 protein content 
in males (solid trendline; y = 13.974x + 0.538, R2 = 0.33, p < 0.05) and females (dashed 
trendline; y = 19.211x + 0.5923, R2 = 0.07, p = 0.50). PDP, pyruvate dehydrogenase 
phophatase. 
Analysis between PDP1, Ela, E2, and COX IV proteins (Table 4.6) revealed 
significant positive correlations between PDPI and Ela for male subjects (r= 0.50; p< 
0.05) as well as significant positive correlations between PDPI and COX IV for all 
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subjects combined (r= 0.45; p= 0.01) and females alone (r= 0.71; p= 0.01). Ela was also 
found to be positively correlated with COX IV for all subjects combined (r= 0.49; p< 
0.01) and males alone (r= 0.46; p= 0.05). E2 was also positively correlated with COX IV 
and Ela for all subjects and males alone. 
Table 4.6. Correlations of mitochondrial protein content in males, females, and 
combined. 
Protein PDPI Ela E2 
slope p slope p slope p 
ALL (N= 29) 0.2907 0.07 
Ela MALES (N= 18) 0.3123 0.04 
FEMALES (N= 11) 0.2539 0.52 
ALL 0.2526 0.34 0.7228 0.02 
E2 MALES 0.4352 0.13 0.8837 0.05 
FEMALES 0.0537 0.92 0.5239 0.23 
ALL 0.4845 0.01 0.623 <0.01 0.3473 0.02 
COX IV MALES 0.1923 0.36 0.6189 0.05 0.4728 <0.01 
FEMALES 0.9864 0.01 0.6808 0.06 0.1629 0.59 
Values are p values and slopes from Pearson's correlation coefficients. Significant values 
are underlined in bold italics; trends are shown in bold. CS, citrate synthase; PDP, 
pyruvate dehydrogenase phosphatase. 
Interestingly, when both PDPl and Ela protein content were normalized to E2 
protein content there was a highly significant positive correlation for all subjects 
combined (r= 0.80; p< 0.001; Figure 4.5B) and for males (r= 0.83; p< 0.001) and females 
(r= 0.77; p= 0.005) separately. 
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Figure 4.5. Scatterplot of the correlation between PDPl and Ela protein content in males 
(solid trendline; A: y = 0.3123x + 0.4436, R2 = 0.25, P < 0.05; B: y = 0.9672x + 0.2746, 
R2 = 0.69, P < 0.001) and females (dashed trendline; A: y = 0.2539x + 0.4706, R2 = 0.05, 
P = 0.52; B: y = 0.9594x + 0.0879, R2 = 0.60, P < 0.01) before (A) and after (B) both 
proteins were normalized to E2 protein content. PDP, pyruvate dehyrogenase 
phosphatase. 
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E2 proteins. 
49 
CHAPTERS: 
DISCUSSION 
To our knowledge, this is the first study to examine PDP activity in human 
skeletal muscle, thereby showing that PDP activity can, indeed, be measured in human 
skeletal muscle. The major findings of the present study were: 1) PDP activity increases 
with increasing aerobic capacity in males; 2) PDPl protein increases with increasing 
aerobic capacity in males, with these two findings resulting in an expected significant 
correlation between PDP! protein and PDP activity in males; 3) E2 increased with 
increasing aerobic capacity, exclusively in males; and 4) when normalized to E2, there 
was a very strong positive correlation between PDP! and Ela in both sexes. 
PDP activity and PDP1 protein content 
One of the most significant findings ofthis study was that of PDP activity 
increasing with aerobic capacity, particularly in males. With previous findings that both 
PDHt activity and PDK activity are increased in human skeletal muscle (in males) 
following 8 weeks of aerobic exercise training, it would seem necessary that PDP activity 
would also need to increase to allow for an adequate activation ofPDH when it is needed 
for energy production. Therefore, at the onset of exercise when an increase in A TP 
production is needed, it can be quickly met through the activation ofPDH by Ca2+ 
stimulation of PDP 1 and then later "fine-tuned" by allosteric regulation ofPDK, 
according to the cellular energy status, to allow for the conservation of carbohydrates 
(LeBlanc et aI., 2004a). This "fine-tuning" by allosteric regulation is accomplished by 
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the varying concentrations ofNADH, ATP, and acetyl-CoA in the cells. With an 
increase in energy demand by the body (i.e. maximal exercise), the concentrations of 
these metabolites will decrease as the acetyl-CoA will be used in the TCA cycle to 
generate more NADH with this NADH in tum being used in the electron transport chain 
to generate A TP for muscle contraction. During maximal exercise these metabolites will 
be used very rapidly, meaning that they will not be able to accumulate, thereby releasing 
their stimulation ofPDK to inactivate PDH. At maximal exercise there will also be an 
increase in glycolysis to help meet the higher energy demands, which will lead to an 
accumulation of pyruvate, thereby further inhibiting PDK activity (especially PDK2 as it 
is the most sensitive isoforrn to pyruvate inhibition; see Figure S.lB). However, during 
submaximal exercise there will be an increased reliance on fat oxidation which would 
cause an increase in NADH and acetyl-CoA, via ~-oxidation, and a decreased usage of 
these metabolites due to the decreased requirement for them at a submaximal workload. 
As a result, PDK activity (specifically PDK2 & 4, as these are the two isoforrns that are 
most responsive to acetyl-CoA and NADH, respectively) will be stimulated leading to a 
decrease in PDHa activity. At the same time, these metabolites (NADH, ATP, and 
acetyl-CoA) also inhibit PDP activity, which means that in situations where these 
metabolites are increased (i.e. submaximal exercise) PDP activity will be decreased, 
thereby enhancing the phosphorylated state ofPDH and causing inactivation of the 
complex (see Figure S.IA). Therefore, after the body's initial responses to exercise 
(increases in [Ca2+] and [pyruvate] in the muscle cell, which activate PDH via increased 
PDP activity and decreased PDK activity, respectively), the concentrations of the 
products of the PDH reaction (NADH and acetyl-CoA) and ATP provide more specific 
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Figure 5.1. Representation of a model of the adaptive changes to PDH complex 
regulation at submaximal (A) and maximal (B) exercise following aerobic training. Text 
size indicates an increase in protein content; bold indicates an increase in enzyme activity 
or metabolite expression. PDH, pyruvate dehydrogenase; PDP, PDH phosphatase; PDK, 
PDHkinase. 
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adjustments to the activities of the regulatory proteins of the PDH complex, thereby 
"fine-tuning" PDHa activity. Therefore, it would seem that with training the body has an 
increased maximal capacity for carbohydrate oxidation, but is also able to more tightly 
regulate carbohydrate oxidation (LeBlanc et aI., 2008), by allowing it to be used when 
needed for quick energy production at higher work intensities, but conserving 
carbohydrates during submaximal exercise with an increased reliance on fat oxidation (as 
reviewed by Holloszy & Coyle, 1984). This finding of increased PDP activity with 
increased aerobic capacity is in agreement with LeBlanc et al. (2008) who found that 8 
weeks of endurance training lead to an increase in PDP activity in obese rats, with a trend 
towards increased activity in lean rats. Of note here is that our data also showed that the 
PDP activity values of human skeletal muscle (~0.52nmols/min/mg mitochondrial 
protein) are consistent with those of rat skeletal muscle (~0.55rimols/min/mg 
mitochondrial protein; LeBlanc et aI., 2007, LeBlanc et aI., 2008). Although none ofthe 
subjects in the current study could be classified as obese according to BMI « 30; see 
Table 4.1), it would appear that our cross sectional data is consistent with what has been 
observed in rats in a longitudinal study. The fact that lean rats were shy of statistical 
significance may be attributed to training duration, as the rats underwent a training period 
of 8 weeks, whereas the current study employed a V02peak test in which subjects had 
maintained a consistent activity level for at least 6 months prior to the test. Therefore, a 
longer duration of training may be required to see significant differences in PDP activity 
in leaner individuals. However, one cannot dismiss the fact that the current study is 
cross-sectional in nature, and therefore, any changes observed in PDP activity cannot 
necessarily be directly attributed to training. It is also possible that these differences in 
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PDP activity are a result of insulin sensitivity as insulin sensitivity is known to increase 
with aerobic exercise training (see Zanuso et aI., 2009 for review) and since PDP is 
known to be stimulated by insulin, this may be the cause ofthe increased PDP activity 
with aerobic capacity. We cannot rule out the effect of genetics either as this has been 
shown to be a primary determinant of aerobic capacity (Klissouras, 1971), especially at 
the whole body level (i.e. V02peak), and may therefore be playing a role in the correlations 
with enzyme activity. Lastly, recent findings demonstrating the phosphorylation of PDP 
(Caruso et aI., 2001) represent another potential source for these differences as it is 
possible that the changes in PDP activity may be a result of PDP phosphorylation. 
Along with the increase in PDP activity seen with increasing aerobic capacity, 
there was also a significant increase in PDPl protein content with muscle aerobic 
capacity (i.e. citrate synthase activity) in all subjects, with male subjects also showing a 
significant correlation with whole body aerobic capacity (absolute V02max). This is also 
similar to what was previously observed in rats (LeBlanc et aI., 2008). This increase in 
protein content would be expected, as PDPl is the calcium-sensitive isoform of PDP and 
would, therefore, allow for increased activation ofPDH during muscle contraction when 
cytosolic calcium levels are raised and there is an increased requirement for carbohydrate 
oxidation to meet energy needs. 
In comparing PDP activity with PDP} protein content, a positive correlation was 
found in all subjects when PDP activity was expressed relative to wet tissue weight, and 
in male subjects alone when activity was expressed relative to mitochondrial protein. 
This suggests that the increase in PDP! protein content seen with increasing aerobic 
capacity is largely responsible for the increase in PDP activity seen with increasing 
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aerobic capacity in males. This is not surprising since PDP} is the predominant isoforrn 
in skeletal muscle (Huang et aI., 1998), and therefore, any changes in its content (i.e. an 
increase) should result in an increase in maximal activity as well. 
This finding of the relationship between protein content and activity has also been 
seen on the other side ofPDH regulation, with that ofPDK. LeBlanc et al. (2004b) found 
that with 8 weeks of aerobic training there was an approximate doubling ofPDK activity, 
which was accompanied by a 1.3-fold increase in PDK2 protein content, again showing 
that increased protein content seems to be a significant cause for increased enzyme 
activity. Therefore, it would appear that there is a strong correlation between the protein 
content of the predominant PDH regulatory proteins in skeletal muscle, PDK2 and PDP 1, 
and the maximal activity levels of the kinase and phosphatase in this tissue, respectively. 
PDH subunit content 
The present study found higher Ela content with increasing muscle aerobic 
capacity in all subjects, which is consistent with previous findings that the protein content 
of E 1 a and PDK2 increase with 8 weeks of aerobic exercise training in humans (LeBlanc 
et aI., 2004b). This increase in Ela is of particular importance though, as it is the rate-
limiting step in the PDH reaction. Therefore, an increase in this subunit with training 
would allow for a greater maximal flux of carbohydrates through PDH, which would lead 
to an increased rate of energy production. In addition to this, E 1 a and PDP 1 protein 
content were shown to increase together. This is largely to be expected though, as an 
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increase in E 1 u would require an increase in the regulatory subunit to activate it, 
especially with the previously observed increase in PDK2 with training which would 
inactivate E 1 u. These findings will be discussed in greater detail later. 
Previous work looking at the effects of training on changes in the content of the 
various subunits ofPDH found that the subunits do not increase in a unifonn manner as 
E2 and E3BP (unlike Ela) demonstrated no significant increases in activity following 8 
weeks of endurance training (LeBlanc et aI., 2004b). In contrast, however, the present 
study, in which subjects had maintained a similar training status for at least 6 months, did 
find a correlation between muscle aerobic capacity and E2 protein content for all 
subjects, with males in particular showing strong correlations with all aerobic capacity 
measures. Therefore, taken together, it may be suggested that the protein content of 
certain subunits (E2 in this case) requires a greater duration of training to observe 
significant differences. This suggestion is also supported by the finding of a clear trend 
for an increase in the protein contents ofE2 and E3BP in humans following 8 weeks of 
training, despite a lack of significance (LeBlanc et aI., 2004b). Taken together, the trend 
towards increased E2 after 8 weeks of training and a significant correlation with aerobic 
capacity in the present study, it would seem that E2 (and very likely E3BP) also increase 
in protein content with training, albeit at a slower rate than that of E 1 a. This may be 
explained in the context that, as already stated, Ela is the rate-limiting step in the PDH 
reaction (Cate et aI., 1980), therefore it would be of greater importance to increase the 
content of this subunit before that ofE2. Therefore, with training there is an increase in 
E 1 a content which allows for a greater maximal flux of carbohydrates for oxidation, and 
therefore, a greater amount of energy to be produced for continued exercise at high 
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intensities. Following the more rapid increase in Ela content, there is also an increase in 
E2 (and very likely other PDH subunits as well, as noted by the trending increase in 
E3BP) which would again allow for increased carbohydrate oxidation by creating more 
lipoyl binding domains for E 1 a to attach to, allowing for a more rapid transfer of the 
acetyl intermediate to E2 for further oxidation. In addition, when E 1 a is bound to the 
complex there is a greater ability for PDP and PDK to dephosphorylate and 
phosphorylate the subunit (Ono et aI., 1993, Pettit et aI., 1972). Therefore, an increase in 
E2 could also be seen as enhancing the ability to tightly regulate the activity of the 
complex by allowing for the more rapid activation or deactivation of the complex through 
the binding of E 1 a to its binding domain. 
With the finding that the core ofthe PDH complex, E2, is more highly expressed 
with a higher aerobic capacity, we decided to investigate whether Ela and PDP! still 
showed significant increases when increases in the PDH core were compensated for. It 
was found that the content of both PDP} and Ela proteins was greater than the E2 core, 
but more interestingly, that these proteins co-ordinately increase relative to E2 (Figure 
4.5B). Accounting for the E2 core is also important as the binding domains for both Ela 
and PDP! are located on the "swinging arm" ofE2. Therefore, it would be inefficient if 
either El a or PDP 1 were to increase faster than the other in comparison to E2, as both 
proteins must be bound to their respective binding domains on E2 in order for 
dephosphorylation to occur, and each E2 subunit has only one binding domain for both 
E 1 a and PDP 1. An increase in either protein over the other would most likely result in 
the lesser protein being a limiting factor in the PDH reaction, thereby making the increase 
in that protein futile. Interestingly, females also showed a strong positive correlation 
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between Ela and PDPl when expressed relative to E2, despite showing very few 
correlations with aerobic capacity when E I a and PDP 1 were expressed on their own. 
With both females and males showing significance in this correlation, it suggests that the 
PDH complex varies together as a whole, with Ela and PDPl increasing at the same rate 
relative to the core of the PDH complex regardless of the magnitude of change relative to 
oxidative capacity. 
Sex differences 
Despite numerous significant correlations between aerobic capacity and PDP 
activity and several proteins of the PDH complex (Ela, E2, and PDPl) in male subjects, 
there were very few correlations (even considering the trends) between aerobic capacity 
and PDP activity and proteins ofthe PDH complex in females alone. However, this is 
not entirely unexpected, since numerous studies have shown that females differ from 
males in terms of fuel selection during aerobic activities. In these studies it has been 
found that recreationally active and endurance trained women utilize less carbohydrate 
than men, who were matched by V02peak to the women, during moderate-intensity 
exercise (Devries et aI., 2006, Tarnopolsky et aI., 1990). Therefore, it is entirely possible 
that the enzymes involved in carbohydrate metabolism and those regulating them would 
be affected by, if not causing the effect of, a decreased usage of carbohydrates in females. 
Therefore, the lack of a correlation seen between PDP activity and aerobic capacity in 
females may be a result of their decreased carbohydrate utilization, in comparison to 
males, and therefore, they require less activation ofPDH by PDP. However, it should 
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also be noted that there have been differences seen in substrate utilization between the 
phases of the menstrual cycle, with the common finding that women use more 
carbohydrates in the follicular phase than the luteal phase (Devries et aI., 2006, Campbell 
et aI., 200 I, Zderic et al., 2001). In the present study, menstrual cycle phase was not 
accounted for, making it possible that the reason for differences in sex were a result of the 
majority of females being tested in the luteal phase, however, this is only speculation and 
cannot be confirmed. However, there have also been several studies demonstrating no 
differences in substrate utilization between the menstrual cycle phases (Casazza et aI., 
2004, Suh et aI., 2002, Suh et aI., 2003). Therefore, future research in this area should 
give consideration to the differences between the sexes as well as possible differences in 
the phases of the female menstrual cycle. 
Although there was no significant correlation in females between aerobic capacity 
and PDP activity, there was a trend for an increase in PDP! protein content with relative 
V02peak and CS activity relative to mitochondrial protein. Therefore, the protein content 
does appear to be there if increased PDH activation is required. Additionally, there was 
no difference seen in total PDP activity between males and females (Table 4.1). This is 
not what would be expected, as females would be expected to have lower activity values 
for PDP since they rely less on carbohydrate metabolism for energy production, and 
therefore, would have less of a need for PDH activation by PDP in comparison to males. 
However, the activity values in this study are maximal in nature, therefore it is possible 
that there is a disconnect between maximal activity and that which is observed acutely in 
vivo. Taken together, with a trend toward increased PDP! protein content with aerobic 
capacity, and a lack of difference between maximal enzyme activities between males and 
59 
females, it is possible that females rely on another level of post-translational PDP 
regulation. 
Possible sources for sex differences 
A possible source of these differences is that females may rely more on the 
phosphorylation of PDP to regulate PDP activity, as this would lend some explanation to 
the differences between PDP 1 protein content and that of maximal activity when 
compared to aerobic capacity. However, research investigating the possibility of PDP 
phosphorylation is still ongoing and has not yet been proven to be physiologically 
relevant in skeletal muscle (Caruso et aI., 2001). Alternatively, the levels ofPDP2 
protein and its activity cannot be overlooked, as females may rely on it more heavily than 
males. Numerous studies have found that 17~-estradiol (E2; the main form of estrogen in 
the body) plays a role in insulin sensitivity in the body (Puah & Bailey, 1985, Kumagai et 
aI., 1993, Gonzalez et aI., 2000, Ordonez et aI., 2008) and with estrogen being the main 
female sex hormone this could playa large role in substrate utilization by females. Puah 
& Bailey (1985) found "evidence that E2 promotes insulin-mediated glucose uptake and 
utilization in skeletal muscle." Therefore, given the higher concentrations ofE2 in 
females and its effects on insulin, it is possible that females do rely more on the insulin 
sensitive isoform, PDP2, for activation of the PDH complex. If females do indeed rely 
more heavily on PDP2, this could represent another factor influencing the decreased 
utilization of carbohydrates by females as PDP2 has been found to have a decreased 
ability to reactivate the PDH complex than that of PDP 1 , especially when more than one 
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site has been phosphorylated. This would lead to a decrease in PDHa activity, and 
therefore, there would be a decreased utilization of carbohydrates. However, further 
research would be required to investigate this theory. 
The possibility of differences in muscle fibre types between the sexes influencing 
our results cannot be dismissed either, as no analysis was done to determine the 
proportion of type I and IIa fibres in the biopsies taken. Several studies have found that 
females have a smaller proportion of type II fibres (with values ranging from 7-19% less; 
Simoneau & Bouchard, 1989, Miller et aI., 1993, Carter et aI., 2001) and a greater 
proportion oftype I fibres (with values ranging from 9-11 % more; Simoneau & 
Bouchard, 1989, Carter et aI., 2001) when compared with males (Brooke & Engel, 1969), 
leading to a strong possibility that this was also the case in the present study. The 
possibility of fibre type being a cause for the sex differences observed between males and 
females is given greater weight by the findings of LeBlanc et aI. (2007 & 2008) which 
found that PDP 1 protein content is significantly greater in the red gastrocnemius 
(predominantly type IIa fibres, with some type I) than white gastrocnemius 
(predominantly type lIb) and soleus (predominantly type I) of rat skeletal muscle. In 
addition to this, it was found that PDP2 protein is only expressed in red gastrocnemius of 
rats, with no detectable levels in other fibre types. Therefore, with the decreased 
proportion of type II fibres seen in females compared to males (Simoneau & Bourchard, 
1989, Miller et aI, 1993, Carter et aI., 2001), it would seem that females would have less 
of both PDP isoforms since both isoforms seem to be expressed to a greater degree in 
type IIa muscle fibres. With a decrease in the content of PDP as a result of these fibre 
type differences, this could further explain the lack of significant correlations seen in 
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females between PDP! content and aerobic capacity measures. However, more research 
is required on this as these studies were done on male rats, therefore it cannot be said for 
certain that PDPl and PDP2 proteins would be expressed in female fibre types the same 
as that of males. Nevertheless, a study by Carter et al. (2001) demonstrates the strong 
possibility that fibre type differences between the sexes is a large factor for the 
differences in carbohydrate and fat metabolism, as they found that males and females do 
not have differences in the maximal activities of several enzymes responsible for p-
oxidation, the TCA cycle, and the electron transport chain. Without differences in the 
maximal enzyme activities of these metabolic pathways, especially p-oxidation, it could 
be postulated that the differences in substrate metabolism between the sexes are a result 
of different expressions and locations of these enzymes in the body (particularly muscle). 
When comparing whole body aerobic capacity (V02peak) against mitochondrial 
oxidative capacity (CS activity), our data demonstrated that males had a significant 
correlation between the two measures, while females did not show any correlation. 
However, this discrepancy can probably be explained by body composition as it has long 
been established that females have a higher body fat percentage than males, with males 
possessing a much greater lean mass (see Wells, 2007 for review). When expressed 
relative to fat free mass, it has been found that there is no difference in V02peak between 
males and females (Devries et aI., 2006). Therefore, it would be expected that CS 
measures would be far more representative of the true aerobic capacity for females as this 
would eliminate the confounding factor of their excess adipose tissue. This appears to be 
the case as significant correlations that were seen in males between aerobic capacity (both 
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VOZpeak and CS measurements) and protein content were usually only seen in females 
when comparing protein content against CS measures. 
However, it should be noted that in the present study there were fewer females 
(n= 12) than males (n= 18), with a smaller range in values for aerobic capacity in the 
females as well. Therefore, it is possible that due to the smaller sample size of our female 
volunteers, and the fact that they represented a less heterogeneous mixture of aerobic 
capacity compared to our males, it was simply more difficult to make solid significant 
correlations. 
Conclusions 
These data strongly suggest that the changes seen in PDP activity and PDP 1 
protein content are a result of aerobic capacity relative to training status, but cause and 
effect cannot be conclusively proven due to the cross-sectional design of this study. 
However, many of our observations are in agreement with previous longitudinal training 
studies in both rats and humans, lending support to the strong possibility that the novel 
findings in this study are indeed because of differences in aerobic training status. 
Therefore, since our results demonstrate that E 1 a and PDP 1 content increase co-
ordinately relative to the complex, and previous work showed that E 1 a subunit content 
increased with 8 weeks of aerobic training (LeBlanc et at, 2004b), it follows that a 
similar increase in PDP} protein content would occur with 8 weeks of aerobic training. 
Additionally, an increase in PDP activity and PDP 1 protein content has already been 
noted in a rat model, making it highly possible that such differences also exist in other 
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mammals (e.g. humans). However, further longitudinal training studies are necessary to 
confirm the findings in the present study, and it will be necessary to study males and 
females separately. 
Some caution should be taken in extrapolating PDP activity values to in vivo 
maximal activity rates, as the present study investigated activity using a synthetic peptide 
substrate (rather than the natural intact complex substrate) under in vitro assay conditions. 
In addition, our assay measures total PDP activity and cannot differentiate between the 
PDP} and PDP2 contributions. As it has been found that PDPl and PDP2 display 
different sensitivities toward the different phosphorylation sites on E 1 a (Kolobova et aI., 
2001, Karpova et aI., 2003), it is difficult to determine how the increased activity of PDP 
would specifically relate to E 1 a activation in vivo. However, as the data in this study 
would suggest, the increase in PDP activity is largely the result of an increase in the 
content of PDP 1 (at least in male subjects), and as this is the isoform that has been found 
to have a higher specific activity towards the Ela phosphorylation sites (Kolobova et aI., 
2001, Karpova et aI., 2003), it would be expected that the increased activity seen here 
should lead to an increased activation of the E 1 a subunit in exercising human skeletal 
muscle. 
Taking the training studies together (LeBlanc et al., 2008, LeBlanc et aI., 2004b) 
with the data from this study, a model ofPDH complex regulation during exercise is 
emerging. As a result of training, there is an increase in the ability of the body to oxidize 
carbohydrates for immediate energy production due to an increase in the E 1 a subunit of 
PDH. However, there is also an increase in the body's ability to regulate this depending 
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on the intensity at which the body is working. During submaximal exercise the body is 
able to decrease carbohydrate oxidation by inactivating PDH through PDK2, which 
increases in content following training, and is strongly activated by acetyl-CoA which 
would be produced in great amounts by ~-oxidation of fats (see Figure 5.IA). However, 
at maximal exercise PDH is activated by the elevated content of PDP 1, which is itself 
activated by the increased levels of cytosolic Ca2+ that occur with muscle contraction. 
Additionally, the elevated levels ofPDK2 are inactivated due to this isoform's high 
inhibition by pyruvate, which will be produced in large amounts by glycolysis in order to 
meet the body's high energy demands at maximal exercise, allowing for greater 
activation ofPDH (see Figure 5.1B). 
Future Directions 
The present study was, to the best of our knowledge, the first to examine PDP 
activity in human skeletal muscle and found that with increasing aerobic capacity there is 
an increase in PDP activity and PDP I protein expression. However, future work should 
focus on extending the results of this cross-sectional study by examining PDP activity 
and expression in humans in a longitudinal training study. Also, in determining protein 
expression, only the PDPI isoform was investigated (as there is no commercially 
available antibody for human PDP2), meaning that we cannot rule out the influence that 
PDP2 may have had on overall PDP activity. Therefore, future analysis should include 
both PDP I and PDP2 isoforms when investigating the effects oftraining. 
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Additionally, the general lack of correlation for females in many PDP activity and 
expression measures indicates that more research is needed to investigate the differences 
in PDH complex regulation between males and females, specifically concerning the 
female menstrual phase, as well as lean body mass and skeletal muscle fibre type. 
Previous studies have found that there are differences in substrate utilization between the 
phases of the menstrual cycle (Devries et aI., 2006, Campbell et aI., 2001, Zderic et aI., 
2001), therefore the effects of this on PDP activity and expression, as it relates to 
carbohydrate oxidation, should be further investigated in both the luteal and follicular 
phases of the menstrual cycle. 
Analysis of the different skeletal muscle fibre types would also be an important 
consideration for future studies in humans, since previous studies have already 
determined differences in PDP activity and expression in rodent models (LeBlanc et aI., 
2007, LeBlanc et aI., 2008). These differences between fibre types could also lead to a 
better understanding of the divergent results observed between males and females in this 
study, as males and females appear to have different fibre type distributions. 
Lastly, the Ihr 21,000g spin used in the methods of the present study removed the 
mitochondrial membrane from the sample, meaning that PDP activity was analyzed from 
the mitochondrial matrix alone. However, studies have suggested that PDP may be 
closely associated with the inner mitochondrial membrane (Simonot et aI., 1997), making 
it possible that there may be some PDP activity (if not greater activity) in the membrane 
portion if it were to be analyzed. Therefore, future studies should also include analysis of 
the mitochondrial membrane for PDP activity. 
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Implications and Perspectives 
Carbohydrates are an exceedingly important fuel source for the body because they 
can supply A TP at a rapid rate when needed, and certain tissues rely on them solely for 
energy production (see Fehm et aI., 2006 for review). Additionally, the tremendous 
increase in the prevalence of type II diabetes mellitus (T2DM) over the past decades, 
largely due to the obesity epidemic, has lead to an even greater focus on carbohydrate 
metabolism and glucose homeostasis in the body. Therefore, understanding the body's 
uptake, storage, and usage of carbohydrates is of great importance in helping curb the 
present trends in the health status of society. A main area of focus for this research has 
been in establishing ways to maintain normal blood glucose concentrations, possibly by 
reducing the plasma glucose concentration through oxidative skeletal muscle disposal 
(see Stump et aI., 2006 for review). Therefore, PDH may playa large role in maintaining 
blood glucose levels at nomial concentrations in those with T2DM or some level of 
insulin resistance. Recent findings seem to indicate this very theory, as they found that in 
the skeletal muscle ofPDK4 knockout (PDK4-/) mice that were fed a high-fat diet there 
was greater PDHa activity in comparison to wild-type mice that were fed the same diet. 
Along with this, they found that PDK4-1- mice had improved glucose tolerance, lower 
fasting blood glucose levels, and greater insulin sensitivity in comparison to their wild-
type counterparts (Jeoung & Harris, 2008). These findings imply that PDHa activity can 
playa role in enhancing insulin sensitivity and ameliorating high plasma glucose 
concentrations in those with T2DM. An increase in PDP! protein with exercise would be 
of great importance to this, as those with T2DM (or some level of insulin resistance) have 
a decreased ability to respond to insulin, which means that they will have to rely more on 
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the calcium-sensitive isofonn of PDP 1 , than the insulin-sensitive PDP2 isofonn, in order 
to activate the PDH complex to decrease glucose levels. Therefore, the findings in the 
present study that PDP activity and PDP1 protein expression increase with aerobic 
capacity (which increases with training; see Powers & Criswell, 1996 for review) 
potentially presents good prospects for those with T2DM to correct insulin sensitivity and 
hyperglycaernia by allowing for increased PDHa activity. 
68 
References 
1. Bajotto, F. Murakami, T., Nagasaki, M., Tamura, T., Tamura, N., Harris, R.A., 
Shimomura, Y. & Sato, Y. (2004). Downregulation of the skeletal muscle 
pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat 
both before and after the onset of diabetes mellitus. Lifo Sci, 75,2117-2130. 
2. Baxter, M.A. & Coore, H.G. (1979). Reduction of mitochondrial pyruvate 
dehydrogenase phosphatase activity in lactating rat mammary gland following 
starvation or insulin deprivation. Biochem Biophys Res Commun, 87,433-440. 
3. Behal, R.H., Buxton, D.B., Robertson, J.G. & Olson, M.S. (1993). Regulation of 
the pyruvate dehydrogenase multi enzyme complex. Ann Rev Nutr, 13,497-520. 
4. Benelli, C., Caron, M., de Galle, B., Fouque, F., Cherqui, C. & Clot, J.P. (1994). 
Evidence for a role of protein kinase C in the activation of the pyruvate 
dehydrogenase complex by insulin in Zajdela hepatoma cells. Metabolism, 43, 
1030-1034. 
5. Bowker-Kinley, M.M., Davis, W.I., Wu, P., Harris, R.A. & Popov, K.M. (1998). 
Evidence for existence of tissue-specific regulation of the mammalian pyruvate 
dehydrogenase complex. Biochem J, 329, 191-196. 
6. Bradley, N.S., Heigenhauser, G.J.F., Roy, B.D., Staples, E.M., Inglis, J.G., 
LeBlanc, P.J. & Peters, S.J. (2008). The acute effects of differential dietary fatty 
acids on human skeletal muscle pyruvate dehydrogenase activity. J Appl Physiol, 
104, 1-9. 
7. Brautigam, C., Wynn, R., Chuang, J. & Chuang, D. (2009). Subunit and 
catalytic-component stoichiometries of an in vitro reconstituted human pyruvate 
69 
dehydrogenase complex. J BioI Chern, [Epub ahead ofprintJ. 
8. Brooke, M.H. & Engel, W.K. (1969). The histographic analysis of human muscle 
biopsies with regard to fiber types. 1. Adult male and female. Neurology, 19, 
221-233. 
9. Brozinick, J.T.Jr., Patel, V.K. & Dohm, G.L. (1988). Effects of fasting and 
training on pyruvate dehydrogenase activation during exercise. Int J Biochem, 20, 
297-301. 
10. Burgomaster, K.A., Heigenhauser, G.J.F. & Gibala, M.J. (2006). Effect of short-
term sprint interval training on human skeletal muscle carbohydrate metabolism 
during exercise and time-trial performance. J Appl Physiol, 100,2041-2047. 
11. Campbell, S.E., Angul, D.J. & Febbraio, M.A. (2001). Glucose kinetics and 
exercise performance during phases of the menstrual cycle: effect of glucose 
ingestion. Am J Physiol Endocrinol Metab, 281, E817-E825. 
12. Carter, S.L., Rennie, C.D., Hamilton, S.J. & Tamopolsky, M.A. (2001). Changes 
in skeletal muscle in males and females following endurance training. Can J 
Physiol Pharmacol, 79, 386-392. 
13. Caruso, M., Maitan, M.A., Bifulco, G., Miele, C., Vigliotta, G., Oriente, F., 
Formisano, P. & Beguinot, F. (2001). Activation and mitochondrial translocation 
of protein kinase C delta are necessary for insulin stimulation of pyruvate 
dehydrogenase complex activity in muscle and liver cells. J BioI Chem, 276, 
45088-45097. 
14. Cassaza, G.A., Jacobs, K.A., Suh, S-H., Miller, B.F., Horning, M.A. & Brooks, 
G.A. (2004). Menstrual cycle phase and oral contraceptive effects on triglyceride 
70 
mobilization during exercise. J Appl Physiol, 97,302-309. 
15. Cate, R.L., Roche, T.E. & Davis, L.C. (1980). Rapid intersite transfer of acetyl 
groups and movement of pyruvate dehydrogenase component in the kidney 
pyruvate dehydrogenase complex. J BioI Chern, 255, 7556-7562. 
16. Chen, G., Wang, L., Liu, S., Chuang, C. & Roche, T. (1996). Activated function 
of the pyruvate dehydrogenase phosphatase through Ca2+-facilitated binding to the 
inner lipoyl domain of the dihydrolipoyl acetyltransferase. J BioI Chern, 271, 
28064-28070. 
17. Churchill, E.N., Murriel, C.L., Chen, C-H., Mochly-Rosen, D. & Szweda, L.I. 
(2005). Reperfusion-induced translocation of oPKC to cardiac mitochondria 
prevents pyruvate dehydrogenase reactivation. Cire Res, 97, 78-85. 
18. Ciszak, E.M., Korotchkina, L.G., Dominiak, P.M., Sidhu, S. & Patel, M.S. 
(2003). Structural basis for flip-flop action of thiamine pyrophosphate-dependent 
enzymes revealed by human pyruvate dehydrogenase. J BioI Chern, 278,21240-
21246. 
19. Cockburn, B.N. & Coore, H.G. (1995). Starvation reduces pyruvate 
dehydrogenase phosphate phosphatase activity in rat kidney. Mol Celr Bioehern, 
149-150, 131-136. 
20. Das, A., Helps, N., Cohen, P. & Barford, D. (1996). Crystal structure of the 
protein serine/threonine phosphatase 2C at 2.0 A resolution. EMBO J, 15, 6798-
6809. 
21. Dekker, L.V. & Parker, P.J. (1994). Protein kinase C - a question of specificity. 
Trends Bioehern Sci, 19, 73-77. 
71 
22. Denton, R.M., Randle, P.J., Bridges, B.J., Cooper, R.H., Kerbey, A.L., Pask, 
H.T., Severson, D.L., Stansbie, D. & Whitehouse, S. (1975). Regulation of 
mammalian pyruvate dehydrogenase. Mol Cell Biochem, 9,27-53. 
23. Denyer, G., Lam, D., Cooney, G. & Caterson, 1. (1989). Effect of starvation and 
insulin in vivo on the activity ofthe pyruvate dehydrogenase complex in rat 
skeletal muscles. FEBS Lett, 250,464-468. 
24. Devries, M.C., Hamadeh, M.J., Phillips, S.M. & Tarnopolsky, M.A. (2006). 
Menstrual cycle phase and sex influence muscle glycogen utilization and glucose 
turnover during moderate-intensity endurance exercise. Am J Physiol Regul 
1ntegr Comp Physiol, 291, RI 120-RI 128. 
25. Fatania, H.R., Vary, T.C. & Randle, PJ. (1986). Modulation of pyruvate 
dehydrogenase kinas activity in cultured hapatocytes by glucagon and n-
octanoate. Biochem ~ 234, 233-236. 
26. Fehm, H., Kern, W. & Peters, A. (2006). The selfish brain: competition for 
energy resources. Prog Brain Res, 153, 129-140. 
27. Fuller, S.J. & Randle, P.J. (1984). Reversible phosphorylation of pyruvate 
dehydrogenase in rat skeletal-muscle mitochondria. Biochem ~ 219, 635-646. 
28. Gonzalez, C., Alonso, A., Alvarez, N., Diaz, F., Martinez, M., Fernandez, S. & 
Patterson, A. (2000). Role of 17~-estradiol and/or progesterone on insulin 
sensitivity in the rat: implications during pregnancy. J Endocrinol, 166, 283-291. 
29. Gopalakrishnan, S., Rahmatullah, M., Radke, G., Powers-Greenwood, S. & 
Roche, T. (l989). Role of protein X in the function of the mammalian pyruvate 
dehydrogenase complex. Biochem Biophys Res Commun, 160, 715-721. 
72 
30. Gudi, R., Bowker-Kinley, M.M., Kedishvili, N.Y., Zhao, Y. & Popov, K.M. 
(1995). Diversity of the pyruvate dehydrogenase kinase gene family in humans. J 
BioI Chern, 270, 28989-28994. 
31. Gutowski, J.A. & Lienhard, G.E. (1976). Transition state analogs for thiamine 
pyrophosphate-dependent enzymes. J BioI Chern, 251,2863-2866. 
32. Harris, R.A., Bowker-Kinley, M.M., Huang, B., and Wu, P. (2002). Regulation 
of the activity of the pyruvate dehydrogenase complex. Advances in Enzyrne 
Regulation, 42,249-259. 
33. Hiromasa, Y., Fujisawa, T., Aso, Y. & Roche, T. (2004). Organization of the 
cores of the mammalian pyruvate dehydrogenase complex formed byE2 and E2 
plus the E3-binding protein and their capacities to bind the El and E3 
components. J BioI Chern, 279,6921-6933. 
34. Holloszy J.O. & Coyle, E.F. (1984). Adaptations of skeletal muscle to endurance 
exercise and their metabolic consequences. J Appl Physiol Respirat Environ 
Exercise Physiol, 56, 831-838. 
35. Holness, M.J. & Sugden, M.C. (1989). Pyruvate dehydrogenase activities during 
the fed-to-starved transition and on re-feeding after acute or prolonged starvation. 
Biochern J, 258, 529-533. 
36. Holness, M.J., Kraus, A., Harris, R.A. & Sugden, M.C. (2000). Targeted 
upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal 
muscle underlies the stable modification of the regulatory characteristics ofPDK 
induced by high-fat feeding. Diabetes, 49,775-781. 
37. Holness, M.J., MacLennan, P.A., Palmer, T.N. & Sugden, M.C. (1988). The 
73 
disposition of carbohydrate between glycogenesis, lipogenesis and oxidation in 
liver during the starved-to-fed transition. Biochem J, 252,325-330. 
38. Huang, B., Gudi, R., Wu, P., Harris, R.A., Hamilton, J. & Popov, K.M. (1998). 
Isoenzyrnes of pyruvate dehydrogenase phosphatase: DNA-derived amino acid 
sequences, expression, and regulation. J Bioi Chern, 273, 17680-17688. 
39. Huang, B., Wu, P., Popov, K., and Harris, R. (2003). Starvation and diabetes 
reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and 
kidney. Diabetes, 52, 1371-1376. 
40. Jackman, M.R. & Willis, W.T. (1996). Characteristics of mitochondria isolated 
from type I and type lIb skeletal muscle. Am J Physiol, 270, C673-678. 
41. Jeoung, N.H. & Harris, R.A. (2008). Pyruvate dehydrogenase kinase-4 deficiency 
lowers blood glucose and improves glucose tolerance in diet-induced obese mice. 
Am J Physiol Endocrinol Metab, 295, E46-E54. 
42. Jungas, R.L. (1971). Hormonal regulation of pyruvate dehydrogenase. 
Metabolism, 20,43-53. 
43. Karpova, T., Danchuk, S., Huang, B. & Popov, K. (2004). Probing a putative 
active site of the catalytic subunit of pyruvate dehydrogenase phosphatase 1 
(PDPlc) by site-directed mutagenesis. Biochim Biophys Acta, 1700,43-51. 
44. Karpova, T., Danchuk, S., Kolobova, E. & Popov, K. (2003). Characterization of 
the isozyrnes of pyruvate dehydrogenase phosphatase: implications for the 
regulation of pyruvate dehydrogenase activity. Biochim Biophys Acta, 1652, 126-
135. 
45. Klissouras, V. (1971). Heritability of adaptive variation. J Appl Physiol, 31,338-
74 
344. 
46. Kolobova, E., Tuganova, A., Boulatnikov, 1., and Popov, KM. (2001). 
Regulation of pyruvate dehydrogenase activity through phosphorylation at 
multiple sites. Biochem J, 358, 69-77. 
47. Korotchkina, L.G. & Patel, M.S. (1995). Mutagenesis studies of the 
phosphorylation sites of recombinant human pyruvate dehydrogenase. Site-
specific regulation. J BioI Chem, 270, 14297-14304. 
48. Korotchkina, L.G. & Patel, M.S. (2001a). Probing the mechanism of inactivation 
of human pyruvate dehydrogenase by phosphorylation ofthree sites. J BioI 
Chem, 276, 5731-5738. 
49. Korotchkina, L.G. & Patel, M.S. (2001b). Site specificity of four pyruvate 
dehydrogenase kinase isoenzymes toward the three phosphorylation sites of 
human pyruvate dehydrogenase. J BioI Chem, 276,37223-37229. 
50. Kumagai, S., Holmang, A. & Bjomtorp, P. (1993). The effects of oestrogen and 
progesterone on insulin sensitivity in female rats. Acta Physiol Scand, 149,91-
97. 
51. Lawson, J.E. Niu, X.D., Browning, K.S., Trong, H.L., Yan, U. & Reed, L.J. 
(1993). Molecular cloning and expression of the catalytic subunit of bovine 
pyruvate dehydrogenase phosphatase and sequence similarity with protein 
phosphatase. Biochemistry, 32, 8987-8993. 
52. LeBlanc, P.J., Harris, R.A., Peters, S.J. (2007). Skeletal muscle fiber-type 
comparison of pyruvate dehydrogenase phosphatase activity and isoform 
expression in fed and food deprived rats. Am J Physiol Endocrinol Metab, 292, 
75 
E571-E576. 
53. LeBlanc, P.J., Howarth, K.R., Gibala, M.J., and Heigenhauser, G.J. (2004a). 
Effects of 7 wk of endurance training on human skeletal muscle metabolism 
during submaximal exercise. J Appi Physioi, 97,2148-2153. 
54. LeBlanc, P.J., Mulligan, M., Antolic, A., MacPherson, L., Inglis, J.G., Martin, D., 
Roy, B.D., Peters, S.J. (2008). Skeletal muscle type comparison of pyruvate 
dehydrogenase phosphatase activity and isoform expression: effects of obesity 
and endurance training. Am J Physioi Regul Integr Comp Physiol, 295, R1224-
R1230. 
55. LeBlanc, P.J., Peters, S.J., Tunstall, R.J., Cameron-Smith, D., and Heigenhauser, 
G.J. (2004b). Effects of aerobic training on pyruvate dehydrogenase and pyruvate 
dehydrogenase kinase in human skeletal muscle. J Physioi, 557,559-570. 
56. Lindner, D., Gschwendt, M. & Marks, F. (1991). Down-regulation of protein 
kinase C in Swiss 3T3 fibroblasts is independent of its phosphorylating activity. 
Biochem Biophys Res Commun, 176, 1227-1231. 
57. Linn, T.C., Pettit, F.H. & Reed, L.J. (1969). a-keto acid dehydrogenase 
complexes. X. Regulation of the activity of the pyruvate dehydrogenase complex 
from beef kidney mitochondria by phosphorylation and dephosphorylation. Proc 
Nati Acad Sci USA, 62,234-241. 
58. Liu, S., Baker, J.C. & Roche, T.E. (1995). Binding of the pyruvate 
dehydrogenase kinase to recombinant constructs containing the inner lipoyl 
domain ofthe dihydrolipoyl acetyltransferase component. J Bioi Chem, 270, 793-
800. 
76 
59. Makinen, M.W. & Lee, C-P. (1968). Biochemical studies of skeletal muscle 
mitochondria. I. Microanalysis of cytochrome content, oxidative and 
phosphorylase activities of mammalian skeletal muscle mitochondria. Arch 
Biochem Biophys, 126, 75-82. 
60. Margineantu, D.H., Brown, R.M., Brown, G.K., Marcus, A.H. & Capaldi, R.A. 
(2002). Heterogeneous distribution of pyruvate dehydrogenase in the matrix of 
mitochondria. Mitochonrion, 1, 327-338. 
61. Matlib, M.A. & O'Brien, P.J. (1975). Compartmentation of enzymes in the rat 
liver mitochondrial matrix. Arch Biochem Biophys, 167, 193-202. 
62. Miller, A.E., MacDougall, J.D., Tarnopolsky, M.A. & Sale, D.G. (1993). Gender 
differences in strength and muscle fiber characteristics. Eur J Appl Physio/ Occup 
Physiol, 66, 254-262. 
63. Nakai, N., Miyazaki, Y., Sato, Y., Oshida, Y., Nagasaki, M., Tanaka, M., 
Nakashima, K. & Shimomura, Y. (2002). Exercise training increases the activity 
of pyruvate dehydrogenase complex in skeletal muscle of diabetic rats. Endocr J, 
49, 547-554. 
64. Nakai, N., Sato, Y., Oshida, Y., Fujitsuka, N., Yoshimura, A. & Shimomura, Y. 
(1999). Insulin activation of pyruvate dehydrogenase complex is enhanced by 
exercise training. Metabolism, 48,865-869. 
65. Ono, K., Radke, G.A., Roche, T.E. & Rahmatullah, M. (1993). Partial activation 
of the pyruvate dehydrogenase kinase by the lipoyl domain region ofE2 and 
interchange ofthe kinase between lipoyl domain regions. J BioI Chem, 268, 
26135-26143. 
77 
66. Ordonez, P., Moreno, M., Alonso, A., Llaneza, P., Diaz, F. & Gonzalez, C. 
(2008). 17~-Estradiol and/or progesterone protect from insulin resistance in STZ-
induced diabetic rats. J Steroid Biochem Mol BioI, 111, 287-294. 
67. Patel, M.S. & Korotchkina, L.G. (2001). Regulation of mammalian pyruvate 
dehydrogenase complex by phosphorylation: complexity of multiple 
phosphorylation sites and kinases. Exp Mol Med, 33, 191-197. 
68. Peters, S.J. & LeBlanc, P.J. (2004). Metabolic aspects oflow carbohydrate diets 
and exercise. Nutr Metab, 1. 
69. Peters, S.J. (2000). Ph.D. Thesis. University of Guelph, ON, Canada. 
70. Peters, S.J., Harris, R.A., Heigenhauser, G.J.F. & Spriet, L.L. (2001a). Muscle 
fiber type comparison ofPDH kinase activity and isoform expression in fed and 
fasted rats. Am J Physiol Regul Integr Comp Physiol, 280, R661-R668. 
71. Peters, S.J., Harris, R.A., Wu, P., Pehleman, T.L., Heigenhauser, G.J.F. & Spriet, 
L.L. (2001b). Human skeletal muscle PDH kinase activity and isoform 
expression during a 3-day high-fat/low carbohydrate diet. Am J Physiol 
Endocrinol Metab, 281, El151-EI158. 
72. Peters, S.J., st. Arnand, T.A., Howlett, R.A., Heigenhauser, G.J.F. & Spriet, L.L. 
(1998). Human skeletal muscle pyruvate dehydrogenase kinase activity increases 
after a low-carbohydrate diet. Arn J Physiol, 275, E980-E986. 
73. Pettit, F.H., Roche, T.E. & Reed, L.J. (1972). Function of calcium ions in 
pyruvate dehydrogenase phosphatase activity. Biochem Biophys Res Commun, 
49,563-571. 
74. Popov, K.M., Kedishvili, N.Y., Zhao, Y., Gudi, R. & Harris, R.A. (1994). 
78 
Molecular cloning of the p45 subunit of pyruvate dehydrogenase kinase. J BioI 
Chern, 269, 29720-29724. 
75. Powers, S. & Criswell, D. (1996). Adaptive strategies of respiratory muscles in 
response to endurance exercise. Med Sci Sports Exerc, 28, 1115-1122. 
76. Pratt, M.L., Maher, J.F. & Roche, T.E. (1982). Purification of bovine kidney and 
heart pyruvate dehydrogenase phosphatase on sepharose derivatized with the 
pyruvate dehydrogenase complex. Eur J Biochern, 125, 349-355. 
77. Puah, J.A. & Bailey, C.J. (1985). Effect of ovarian hormones on glucose 
metabolism in mouse soleus muscle. Endocrinology, 117, 1336-1340. 
78. Putman, C.T., Jones, N.L., Hultman, E., Hollidge-Horvat, M.G., Bonen, A., 
McConachie, D.R. & Heigenhauser, G.J.F. (1998). Effects of short-term 
submaximal training in humans on muscle metabolism in exercise. Arn J Physiol, 
275, E132-E139. 
79. Rahmatullah, M., Gopalakrishnan, S., Andrews, P., Chang, C., Radke, G. & 
Roche, T. (1989b). Subunit associations in the mammalian pyruvate 
dehydrogenase complex. J BioI Chern, 264,2221-2227. 
80. Rahmatullah, M., Gopalakrishnan, S., Radke, G. & Roche, T. (1989a). Domain 
structures of the dihydrolipoyl transacetylase and the protein X components of 
mammalian pyruvate dehydrogenase complex. J BioI Chern, 264, 1245-1251. 
81. Ravindran, S., Radke, G., Guest, J. & Roche, T. (1996). Lipoyl domain-based 
mechanism for the integrated feedback control of the pyruvate dehydrogenase 
complex by enhancement of pyruvate dehydrogenase kinase activity. J BioI 
Chern, 271, 653-662. 
79 
82. Reed, L.J. & Hackert, M.L. (1990). Structure function relationships in 
dihyrolipoamide acetyltransferases. J Biol Chern, 265, 8971-8974. 
83. Reed, L.J. (1974). Multienzyme complexes. Acc Chern Res, 7,40-46. 
84. Robinson B. & Chun, K (1993). The relationships between transketolase, yeast 
pyruvate decarboxylase and pyruvate dehydrogenase of the pyruvate 
dehydrogenase complex. FEBS Lett, 328, 99-102. 
85. Sale, G.J. & Randle, P.J. (1981). Analysis of site occupancies in 
[32P]phosphorylated pyruvate dehydrogenase complexes by aspartyl-prolyl 
cleavage oftryptic phosphopeptides. Eur J Biochem, 120, 535-540. 
86. Sale, G.J. & Randle, P.J. (1982). Role of individual phosphorylation sites in 
inactivation of pyruvate dehydrogenase complex in rat heart mitochondria. 
Biochem J, 203,99-108. 
87. Seifert, F., Ciszak, E., Korotchkina, L., Golbik, R., Spink a, M., Dominiak, P., 
Sidhu, S., Brauer, J., Patel, M. & Tittmann, K. (2007). Phosphorylation of serine 
264 impedes active site accessibility in the El component ofthe human pyruvate 
dehydrogenase multi enzyme complex. Biochemistry, 46,6277-6287. 
88. Seifert, F., Golbik, R., Brauer, J., Lilie, H., Schroder-Tittmann, K, Hinze, E., 
Korotchkina, L., Patel, M. & Tittmann, K (2006). Direct kinetic evidence for 
half-of-the-sites reactivity in the E 1 component of the human pyruvate 
dehydrogenase multi enzyme complex through alternating sites cofactor 
activation. Biochemistry, 45, 12775-12785. 
89. Severson, D.L., Denton, R.M., Pask, H.T. & Randle, P.J. (1974). Calcium and 
magnesium ions as effectors of adipose-tissue pyruvate dehydrogenase phosphate 
80 
phosphatase. Biochem J, 140,225-237. 
90. Simoneau, J-A. & Bouchard, C. (1989). Human variation in skeletal muscle 
fiber-type proportion and enzyme activities. Endocrinol Metab, 20, E567-E572. 
91. Simonot, C., Lerme, F., Louisot, P. & Gateau-Roesch, o. (1997). Sub-
mitochondrial localization of the catalytic subunit of pyruvate dehydrogenase 
phosphatase. FEBSLett, 401, 158-162. 
92. Smolle, M., Prior, A., Brown, A., Cooper, A. Byron, O. & Lindsay, J. (2006). A 
new level of architectural complexity in the human pyruvate dehydrogenase 
complex. J BioI Chem, 281, 19772-19780. 
93. Srere, P.A. (1969). Citrate synthase. In: Methods in Enzymology, edited by 
Lowenstein, J.M. New York: Academic, p. 3-5. 
94. Stanley, C.J. & Perham, R.N. (1980). Purification of2-oxo acid dehydrogenase 
multi enzyme complexes from ox heart by a new method. Biochem J, 191, 147-
154 
95. Stump, C.S., Henriksen, E.J., Wei, Y. & Sowers, J.R. (2006). The metabolic 
syndrome: role of skeletal muscle metabolism. Ann Med, 38, 389-402. 
96. Sugden, M.C. & Holness, M.J. (1989). Effects ofre-feeding after prolonged 
starvation on pyruvate dehydrogenase activities in heart, diaphragm and selected 
skeletal muscles of the rat. Biochem J, 262,669-672. 
97. Sugden, M.C. & Holness, M.J. (1994). Interactive regulation of the pyruvate 
dehydrogenase complex and the carnitine palmitoyl-transferase system. F ASEB J, 
8,54-61. 
98. Sugden, M.C. & Holness, M.J. (2003). Recent advances in mechanisms 
81 
regulating glucose oxidation at the level of the pyruvate dehydrogenase complex 
by PDKs. Am J Physiol Endocrino/ Metab, 284, E855-E862. 
99. Sugden, M.C., Bulmer, K. & Holness, MJ. (2001). Fuel-sensing mechanisms 
integrating lipid and carbohydrate utilization. Biochem Soc Trans, 29, 272-278. 
100. Sugden, M.C., Fryer, L.G., Orfali, K.A., Priestman, D.A., Donald, E. & Holness, 
M.J. (1998). Studies of the long-term regulation of hepatic pyruvate 
dehydrogenase kinase. Biochem J, 329, 89-94. 
101. Sugden, M.C., Langdown, M.L. & Holness, M.J. (2000). Expression and 
regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart 
and in adulthood: role of thyroid hormone status and lipid supply. Biochem J, 
352, 731-738. 
102. Sugden, P.H. & Randle, P.J. (1978). Regulation of pig heart pyruvate 
dehydrogenase by phosphorylation. Biochem J, 173,659-668. 
103. Sub, S-H., Casazza, G.A., Homing, M.A., Miller, B.F. & Brooks, G.A. (2003). 
Effects of oral contraceptives on glucose flux and substrate oxidation rates during 
rest and exercise. J App/ Physio/, 94, 285-294. 
104. Sub, S-H., Casazza, G.A., Homing, M.A., Miller, B.F. & Brooks, G.A. (2002). 
Luteal and follicular glucose fluxes during rest and exercise in 3-h postabsorptive 
women. J App/ Physio/, 93,42-50. 
105. Tamopolsky, LJ., MacDougall, J.D., Atkinson, S.A., Tamopolsky, M.A. & 
Sutton, J.R. (1990). Gender differences in substrate for endurance exercise. J 
App/ Physio/, 68, 302-308. 
106. Teague, W.M., Pettit, F.H., Wu, T.L., Silberman, S.R. & Reed, L.J. (1982). 
82 
Purification and properties of pyruvate dehydrogenase phosphatase from bovine 
heart and kidney. Biochemistry, 21, 5585-5592. 
107. Teague, W.M., Pettit, F.H., Yeaman, S.J. & Reed, L.J. (1979). Function of 
phosphorylation sites on pyruvate dehydrogenase. Biochem Biophys Res 
Commun, 87, 244-252. 
108. Thomas, A.P. & Denton, R.M. (1986). Use oftoluene-permeabilized 
mitochondria to study the regulation of adipose tissue pyruvate dehydrogenase in 
situ. Biochem J, 238, 93-101. 
109. Turkan, A., Hiromasa, Y. & Roche, T. (2004). Formation ofa complex of the 
catalytic subunit of pyruvate dehydrogenase phosphatase isoform I (PDP I c) and 
the L2 domain forms a Ca2+ binding site and captures PDPI c as a monomer. 
Biochemistry, 43, 15073-15085. 
110. Turvey, E.A., Heigenhauser, G.J.F., Parolin, M. & Peters, S.J. (2004). Elevated 
n-3 fatty acids in a high-fat diet attenuate the increase in PDH kinase activity but 
not PDH activity in human skeletal muscle. J Appl Physiol, 98, 350-355. 
111. Vassylyev, D. & Symersky, J. (2007). Crystal structure of pyruvate 
dehydrogenase phosphatase 1 and its functional implications. J Mol BioI, 370, 
417-426. 
112. Ward, G.R., MacDougall, J.D., Sutton, J.R., Toews, C.J. & Jones, N.L. (1986). 
Activation of human muscle pyruvate dehydrogenase with activity and 
immobilization. Clin Sci (Lond), 70,207-210. 
113. Weiss, L. Loffler, G., Schirmann, A. & Wieland, O. (1971). Control of pyruvate 
dehydrogenase interconversion in adipose tissue by insulin. FEBS Lett, 15, 229-
83 
231. 
114. Wells, J.C.K. (2007). Sexual dimorphism of body composition. Best Pract Res 
Clin Endocrinol Metab, 21,415-430. 
115. Wieland, O.H. (1983). The mammalian pyruvate dehydrogenase complex: 
structure and regulation. Rev Physiol Biochem Pharmacol, 96, 123-170. 
116. Wu, P., Blair, P.V., Sato, J., Jaskiewicz, J., Popov, K.M. & Harris, R.A. (2000). 
Starvation increases the amount of pyruvate dehydrogenase kinase in several 
mammalian tissues. Arch Biochem Biophys, 381, 1-7. 
117. Yan, J., Lawson, J. & Reed, L. (1996). Role of the regulatory subunit of bovine 
pyruvate dehydrogenase phosphatase. Proc Natl Acad Sci, 93,4953-4956. 
118. Yang, D., Gong, X., Yakhnin, A. & Roche, T. (1998). Requirements for the 
adaptor protein role of dihydrolipoyl acetyltransferase in the up-regulated function 
of the pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase. 
J Bioi Chem, 273, 14130-14137. 
119. Yeaman, S.J., Hutcheson, E.T., Roche, T.E., Pettit, F.H., Brown, J.R., Reed, L.J., 
Watson, D.C. & Dixon, G.H. (1978). Sites of phosphorylation on pyruvate 
dehydrogenase from bovine kidney and heart. Biochemistry, 17, 2364-2370. 
120. Zanuso, S., Jimenez, A., Pugliese, G., Corigliano, G. & Balducci, S. (2009). 
Exercise for the management of type 2 diabetes: a review of the evidence. Acta 
Diabetol, [Epub ahead ofprintJ. 
121. Zderic, T.W., Coggan, A.R. & Ruby, B.C. (2001). Glucose kinetics and substrate 
oxidation during exercise in the follicular and luteal phases. J Appl Physiol, 90, 
447-453. 
84 
122. Zhou, Z.H., McCarthy, D.B., O'Connor, C.M., Reed, L.1. & Stoops, 1.K. (2001). 
The remarkable structural and functional organization of the eukaryotic pyruvate 
dehydrogenase complexes. Proc Natl Acad Sci USA, 98, 14802-14807. 
85 
APPENDIX 
Table A.i. Raw data for male subjects 
Subject V02peak CS activity (I-'mols/min) PDP activity (nmols/min) Protein Content, A.U. 
(mllkg/min) (Llmin) (mg mitochondrial (g wet (mg mitochondrial (g wet 
I 
protein) tissue wt) protein) tissue wt) PDP1 E1a E2 COX IV . 
AJ 36 2.7 6.092 14.78 0.217 2.304 0.681 0.281 0.329 0.160 
AT 48 3.8 7.736 19.35 0.437 4.704 0.337 0.464 0.145 0.179 
SF 57 4.7 11.106 26.10 0.818 0.855 0.357 0.708 
SP 54 3.7 11.287 28.67 0.946 18.954 0.713 0.939 0.353 0.374 
CO 49 3.7 6.944 17.21 0.137 1.533 0.507 0.874 0.324 0.381 
JY 49 3.2 9.316 16.49 0.413 2.519 0.455 0.648 0.245 0.634 
KM 55 4.1 6.412 19.75 0.201 3.323 0.565 0.796 0.432 0.422 
MP 65 5.4 11.536 32.30 0.991 16.160 0.938 0.863 0.631 0.692 
NJ 41 3.9 8.091 14.24 0.708 7.059 0.548 0.265 0.223 0.402 
NP 48 4.6 9.628 24.07 1.112 20.667 0.736 1.013 0.342 0.527 
PR 40 3.7 7.679 17.97 0.776 7.287 0.732 0.426 0.160 0.218 
RE 41 3.6 6.508 18.36 0.285 3.505 0.481 0.398 0.152 0.281 
RM 42 3.2 5.418 15.55 0.202 1.899 0.638 0.520 0.095 0.112 
RN 49 3.7 5.648 16.83 0.503 6.355 0.860 0.875 0.145 0.075 
RP 47 4.0 7.433 20.96 0.339 4.322 0.796 0.851 0.195 0.382 
RW 40 3.6 6.355 18.53 0.261 2.788 0.575 0.634 0.312 0.379 
SL 54 4.6 7.554 20.47 0.796 12.888 0.675 0.513 0.117 0.387 
SM 51 3.9 8.196 20.39 0.616 8.875 0.525 0.295 0.224 0.263 
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Table A.2. Raw data for female subjects 
Subject V02peak CS activity (IJmols/min) PDP activity (nmols/min) Protein Content 
(ml/kg/min) (Umin) (mg mitochondrial (g wet (mg mitochondrial (g wet PDP1 E1a E2 COX IV protein) tissue wt) protein) tissue wt) 
AA 43 3.0 7.930 20.05 0.736 10.790 0.839 0.521 0.146 0.278 
CS 44 2.7 6.988 17.77 0.222 2.170 0.592 0.613 0.096 0.452 
ChO 35 2.6 6.171 18.08 0.199 2.177 0.808 0.610 0.451 0.236 
EF 46 3.6 6.307 11.29 1.136 9.748 
HR 39 2.6 5.836 11.64 0.829 7.748 0.477 1.014 0.578 0.382 
KP 46 2.8 9.782 21.33 0.476 7.257 1.316 0.967 0.329 0.821 
LH 40 2.6 10.000 26.14 0.220 3.953 0.557 1.051 0.260 0.286 
MiK 40 2.1 4.654 7.04 0.318 1.663 0.626 0.460 0.160 0.111 
MJ 30 2.3 4.749 10.64 0.372 0.573 0.228 0.216 
MK 42 2.9 6.997 16.78 0.226 2.295 0.474 0.489 0.133 0.184 
SG 33 2.3 7.074 19.16 0.494 0.797 0.275 0.353 
SW 42 2.5 5.924 16.47 0.820 9.546 0.556 0.525 0.540 0.314 
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Figure A.I. Representative Western blot for PDPl. 
Figure A.2. Representative Western blot for Elu. 
Figure A.3. Representative Western blot for E2. 
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Figure A.4. Representative Western blot for COX IV. 
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Figure A.5. Optimization blots for PDPl. Lanes were loaded (from left to right) with 
2.5, 5, and 1 O~g of protein with the primary antibody diluted 1 :2000 (A) and 1: 1 000 (B). 
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Figure A.6. Scatterplot of optimization values for PDP 1 for l: 1000 and 1 :2000 primary 
antibody dilution. 
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